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1 Summary 
Cell type identity is largely determined by regulatory networks consistent of various 
transcription factors. Transcription factor activity requires interaction with DNA and thus 
critically depends on the accessibility of binding motifs. Growing evidence suggests that 
interactions between transcription factors and DNA are modulated by distinct chromatin 
modifications which in turn are influenced by transcription factors. Thus, ultimately 
transcriptional output is a product of intimate interactions between DNA, transcription 
factors and chromatin modifications. While recent studies support a model in which DNA 
sequence in collaboration with transcription factors can autonomously determine 
chromatin states, exact relationship between all these components is not well 
understood. 
Full genome single basepair resolution mammalian methylomes (Hodges et al, 2011; 
Stadler et al, 2011) demonstrated a correlation between transcription factor occupancy 
and hypomethylation at distal regulatory regions. Importantly, these low methylated 
states critically depend on the presence of transcription factors. Here we analyzed how 
DNA binding factors impact DNA methylation. Using chromatin immunoprecipitation 
followed by bisulfite sequencing, we show that CTCF bound molecules can vary in their 
methylation levels at such low methylated regions (LMRs). This observation suggests 
that no tight link exists between DNA binding of transcription factors and unmethylated 
state. While cytosines which are highly occupied by CTCF indeed are fully devoid of 
methylation, cytosines within sites of low occupancy display heterogeneous methylation 
levels. Moreover, at these sites CTCF occupancy correlates with the likelihood of being 
demethylated. 5-hydroxymethylcytosine (5hmC) is a putative intermediate of active 
demethylation. In support of a dynamic model of interaction between transcription factors 
and DNA methylation, we found that 5hmC is highly enriched at cell type specific and 
constitutive LMRs in embryonic stem cells and upon their neuronal differentiation. 
Furthermore, regions with hydroxymethylation changes between these cell types are 
enriched for cell type specific LMRs. This suggests a participation of transcription factor 
mediated oxidative demethylation in reprogramming of distal regulatory elements. 
Knockout of CTCF is lethal for embryonic stem cells. Therefore, in order to test the 
relationship between transcription factor binding and hydroxymethylation we chose an 
embryonic stem (ES) cell line with genetic deletion of REST, another factor previously 
shown to be involved in formation of low methylated states. Indeed, deletion of REST 
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decreased 5-hydroxymethylcytosine levels while concomitantly increasing methylation 
levels at its binding sites within the analyzed LMRs. These results indicate that 
transcription factor mediated turnover of DNA methylation acts in maintenance and 
reprogramming of distal regulatory regions. 
To test whether the observed turnover is selective for active regulatory regions, we 
decided to delete the two de novo DNA methyltransferases DNMT3A and DNMT3B in 
embryonic stem cells. Surprisingly, using this approach we detected loss of methylation 
at both, low and fully methylated regions. In order to compare the turnover kinetics 
between different segment subtypes, we collected DNA from ES cells at various time 
points after DNMT3A/B deletion. This indeed revealed an accelerated turnover at low 
methylated regions. On average full demethylation was achieved after eight days, 
suggesting that binding of transcription factors can induce rapid changes in DNA 
methylation. 
In summary, this study supports a model in which methylation at distal regulatory regions 
is maintained and reprogrammed by a transcription factor mediated turnover. We 
furthermore provide evidence that this turnover depends on TET proteins for 
demethylation and on DNMT3A/B for remethylation. Quantification suggests that while 
DNA methylation turnover is present throughout the genome it is accelerated at active 
distal regulatory elements.  
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2 Introduction 
Mammalian development begins as a single fertilized oocyte followed by multiple cell 
divisions. During this period cells have to accomplish the complicated task of acquiring a 
new identity, ultimately differentiating into many distinct cell types that form an entire 
organism. While the genetic content in differentiated cells remains largely unchanged, 
this genetic information has to be correctly interpreted to execute cell type specific 
functions. As a result, precise regulation of gene expression in space and time is crucial 
for diversification and maintenance of cell fate (Davidson 2010). Considering that 
hundreds of cell types exist in the human body, this represents a challenging and highly 
complex task. To achieve precise orchestration of transcriptional programs, higher 
eukaryotes use several mechanistic layers (Struhl 1999). The first regulatory level is 
given by the patterns encoded in DNA which directly guide DNA binding factors to their 
site of action where these can initiate transcriptional programs. In a second layer, DNA is 
packaged into chromatin by being wrapped around proteins called histones whose 
presence impacts binding of transcription factors. Finally, chromatin can be chemically 
modified. These epigenetic marks can further influence chromatin structure and attract or 
repel additional proteins.  
It is becoming increasingly appreciated that an intricate interplay exists between these 
layers and we are just beginning to understand how they affect each other and 
transcription as a whole. I have extended this knowledge by showing how factor binding 
influences the stability of an epigenetic modification. 
In the following paragraphs I will give a more detailed introduction on gene regulation in 
the context of chromatin and epigenetic modifications. 
  
4 Introduction 
2.1 Transcriptional regulation 
Evolution has been accompanied by a burst of genome size disproportional to the 
increase in gene number. The human haploid genome with its 3.4 gigabases (Gregory 
2014) exceeds the genome size of the bacteria Echerischia coli by a 1000 fold, but 
contains only about seven times as many protein-coding genes. On the other hand, the 
human genome is a 100 times smaller than that of the marbled lungfish Protopterus 
aethiopicus, the animal with the largest known genome. These examples nicely illustrate 
that the complexity of an organism is not dictated by the pure size of the genome.  
In animals expansion in genome size is believed to be caused by an accumulation of 
transposons which make up almost 50% of the human genome (Kidwell 2002). Indeed, 
particularly organisms with obligatory sexual reproduction display an increased likelihood 
of transposon fixation. It has been demonstrated that a transposon has to cause more 
than 50% reduction in the fitness of such an organism in order to be deleted (Bestor 
1999). As transposition represents a threat for genomic stability, parallel invention of 
mechanisms controlling their expression was critical for the survival of species with large 
genomes (Bird 1995; Bestor 1999). It is thus possible that genome expansion together 
with the necessity to repress transposons represent a major driving force for the 
evolution of complex gene regulation mechanisms. 
The basic principle of gene regulation is the interaction of transcription factors with DNA 
sequence. Forced expression of only a few transcription factors is sufficient for 
reprogramming of an adult differentiated cell into a pluripotent stem cell (Takahashi and 
Yamanaka 2006) demonstrating the power of this phenomenon. However, this process is 
rather inefficient and stochastic, suggesting that additional barriers need to be overcome 
in order to ensure robust changes of gene expression. Indeed, while prokaryotes can 
regulate their genes through a combination of transcription (co-)factors and regulatory 
sequences, mammalian gene regulation employs more mechanisms (Joseph et al, 2010; 
Kaplan et al, 2011). 
As a key difference to prokaryotes, eukaryotic DNA is compacted to chromatin by 
histone proteins. In addition to packaging DNA, chromatin creates a general physical 
barrier for transcription, as it renders the DNA less permissive for binding factors 
(Knezetic and Luse 1986; Struhl 1999; Levine and Tjian 2003). The level of compaction 
can further be modulated by chemical modifications of histone proteins which enable 
changes in chromatin accessibility. This can be achieved by altering the electric charge 
of DNA or creating binding sites for effector proteins (Bannister and Kouzarides 2011).  
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In addition, mammalian genomes are decorated by DNA methylation, a covalent 
modification of cytosines present only in large eukaryotic genomes (Bestor 1990). Similar 
to chromatin, it has been proposed to create a genome-wide restrictive state (Bird 1995). 
Recent studies extended the list of covalent DNA modifications to oxidation products of 
DNA methylation, namely hydroxy-, formyl- and carboxymethylation (He et al, 2011; Ito 
et al, 2011). However, their role in gene regulation is less understood (see 2.4.5). DNA 
and histone modifications are currently referred to as “epigenetic modifications”.  
Given this restrictive environment, in order to gain access to their binding site, 
mammalian transcription factors need to overcome a number of physical barriers. As a 
result, mammalian gene regulation is a product of a close collaboration between DNA 
sequences, chromatin modifications and transcription factor binding. Importantly, while 
prokaryotic transcriptional regulation occurs in the absence of chromatin modifications, 
both transcription factors and epigenetic modifiers are essential for mammalian 
development (Nichols et al, 1998; Okano et al, 1999; Ringrose and Paro 2004). Thus, 
mammalian gene regulation cannot be considered separately from the chromatin context 
(Joseph et al, 2010; Kaplan et al, 2011). Exact crosstalk between all these components 
is not fully understood. Yet, several lines of evidence suggest an autonomous function of 
DNA sequence in determining its epigenetic and transcriptional state in a process which 
is largely transcription factor dependent (Lienert et al, 2011; Schubeler 2012; Arnold et 
al, 2013). For instance, promoters and distal regulatory elements can accurately 
reproduce spatial and temporal characteristics of their chromatin and DNA modification 
states when introduced at ectopic sites.  
As this thesis investigates chromatin modifications at distal regulatory elements, I will 
first introduce the major cis-regulatory modules of the genome, namely promoters, 
enhancers and insulators. 
2.1.1 Cis-regulatory elements 
Promoters 
Promoters of protein-coding genes function locally to initiate transcription from the 
transcriptional start site (TSS) by attracting the core transcriptional machinery consisting 
of general transcription factors (such as TFIID) and RNA polymerase II (Pribnow 1975; 
Schaller et al, 1975; Gannon et al, 1979; Corden et al, 1980; Grosschedl et al, 1981). 
Three major types have been described in metazoans: tissue-specific, constitutive and 
developmentally regulated promoters (reviewed in (Lenhard et al, 2012)). These 
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promoters differ in respect to their underlying sequence, their chromatin organization and 
modifications. For example, tissue-specific promoters are DNA methylated and contain a 
TATA-box for recruitment of the basal transcriptional machinery. In contrast, the other 
promoter subtypes display high level of CpG dinucleotides indicative of CpG islands and 
consequently remain mostly DNA unmethylated in any transcriptional state (see 2.4). 
Despite these differences, all active promoters possess similar histone modifications, as 
has been initially observed in yeast (Santos-Rosa et al, 2002; Pokholok et al, 2005) and 
later confirmed for the human genome (Heintzman et al, 2007). This suggests an 
intimate crosstalk between gene expression and their epigenetic state. 
Enhancers 
The activity of the core transcriptional machinery is further modulated by additional 
transcription factors (TFs). These bind to proximal and distal regulatory elements 
(enhancers or silencers) that can be located many megabases away (Banerji et al, 1981; 
Fromm and Berg 1983; Gillies et al, 1983; Scholer and Gruss 1984). Their interaction 
with the transcriptional machinery at promoters is therefore often regulated by chromatin 
looping (reviewed by (Chambeyron and Bickmore 2004; Fraser 2006)).  
Enhancers usually contain clusters of short 6-12 basepair motifs presenting binding sites 
for different TFs (Arnosti and Kulkarni 2005; Boyer et al, 2005; Carroll et al, 2006; Spitz 
and Furlong 2012). In many cases enhancer activity directly depends on combinatorial 
binding of several transcription factors which can be modulated spatially by cell type 
specific (Mullen et al, 2011; Trompouki et al, 2011) or temporally by developmentally 
regulated sequential expression (Cirillo et al, 2002; Serandour et al, 2011).  
Combinatorial binding is useful for many different reasons. In some cases, direct 
interactions can change TF affinity or specificity towards its binding site. For instance, 
cooperative binding can increase the motif affinity of binding partners (Johnson et al, 
1979). Furthermore, interaction with a cofactor which does not bind to DNA itself can 
alter the DNA binding specificity of a TF (Siggers et al, 2011). Binding of one TF may 
also be necessary to recruit other complex-forming factors. In addition to direct protein-
protein interactions, indirect cooperativity is possible by creation of an accessible binding 
site by nucleosome displacement during “assisted loading” (Voss et al, 2011) or 
“collaborative competition” of two transcription factors (Miller and Widom 2003). Another 
well-described phenomenon is chromatin remodeling by “pioneer factors” (Zaret and 
Carroll 2011). Indeed, chromatin accessibility of a motif increases the likelihood of 
binding even for a factor capable of occupying a closed side (John et al, 2011) 
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emphasizing the importance of chromatin remodeling for TF binding. Moreover, 
favorable changes in DNA conformation by a preceding factor can indirectly help 
recruitment of other factors (“bending”, (Falvo et al, 1995)). As an additional mechanism, 
interaction with common enhancer-activating factors, such as CBP/p300, can enhance 
transcriptional activity (Merika et al, 1998).  
Experimentally, location of transcription factors in the genome is determined by 
enrichment-based methods, such as chromatin immunoprecipitation followed by 
sequencing (Furey 2012). Such datasets of a quality sufficient to determine consensus 
motifs only exist for some transcription factors. Out of those, all TFs occupy only a small 
subset of their binding motifs present in the genome (Carr and Biggin 1999; Iyer et al, 
2001; Joseph et al, 2010; Kaplan et al, 2011). How exactly TFs select between multiple 
options is not well understood, however this is likely to involve the different modes of 
cooperation described above.  
Active and poised enhancers are furthermore characterized by specific chromatin 
modifications which enable identification of their genome-wide localization (Heintzman et 
al, 2009; Heintzman and Ren 2009). Although their function is not fully understood these 
modifications could regulate chromatin accessibility and thus enable transcription factor 
binding (Lupien et al, 2008). In addition, enhancers display local hypomethylation only 
when active in a manner that appears dependent on the binding of transcription factors 
(Stadler et al, 2011).  
Insulators 
Insulators exert their regulatory role over entire chromatin regions by separating two 
regulatory domains in the genome (Bell et al, 2001; Phillips-Cremins and Corces 2013). 
One classic insulator activity is enhancer blocking. The most prominent example is 
certainly the H19/Igf2 imprinted locus (Bell et al, 1999). In this locus CTCF binds at an 
insulator element exclusively in the maternal allele and regulates enhancer function to 
repress Igf2 in allele-specific manner. Importantly, allele-specific interaction with CTCF is 
guided by DNA methylation (Bell and Felsenfeld 2000; Hark et al, 2000; Kanduri et al, 
2000). 
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Figure 2-1 Model of transcriptional regulation. Adapted from (Bardet 2012). 
 
 
In summary, concerted gene regulation in animals can be seen as a complex interplay 
between cis- and trans-acting factors, epigenetic modifications and higher-order 
chromatin structures, such as looping or locus position within the nucleus. Despite 
growing data accumulation, limited knowledge exists about exact causality. Do chromatin 
modifications influence transcriptional activity or are they just a footprint of preceding TF 
binding events? Regulatory function implies high stability and accurate inheritance of 
epigenetic marks. Yet, both phenomena are not well understood.  
In the present work I examine the establishment and maintenance of DNA methylation 
patterns at the sites of transcription factor binding. Following paragraphs will introduce 
transcriptional regulatory principles relevant to my work with the main focus on DNA 
methylation. 
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2.2 Chromatin 
In eukaryotes DNA is packaged to chromatin, a unifying term for DNA and all accessory 
proteins. Chromatin can be classified in two groups as defined in 1928 by Emil Heitz 
based on their staining characteristics (reviewed in (Zacharias 1995; Elgin 1996)). 
Euchromatin, the “proper” chromatin, decondensates during the interphase and thus 
behaves according to the original definition of chromatin made by Boveri in 1904 as a 
substance which forms chromosomes during mitosis (cited in (Zacharias 1995)). In 
contrast, following the original definition heterochromatic regions remain highly 
condensed and stained in the interphase. Today this definition has been refined and we 
know that repetitive sequences and transposable elements belong to heterochromatin 
even though for example telomeres do not show the characteristic interphase staining 
and condensation (Elgin 1996).  
The two main chromatin states additionally differ in terms of their chromatin 
modifications, their gene density and their bound proteins. One such characteristic is 
heterochromatic protein HP1 which was originally identified as a protein abundantly 
present at pericentromeric heterochromatin (James et al, 1989). Furthermore, 
heterochromatin contains high levels of histone H3 lysine 9 and DNA methylation 
(Grewal and Rice 2004; Trojer and Reinberg 2007). As indicated by its condensed 
structure, this chromatin form must be rather inaccessible for transcription factors. 
Indeed, two key observations linked heterochromatin with gene silencing: the condensed 
structure of the inactivated X-chromosome (Barr body) and silencing of active genes in 
its vicinity, termed position effect variegation (reviewed in (Elgin 1996)). Based on the 
reversibility of the heterochromatic state heterochromatin is furthermore often subdivided 
into constitutive and facultative heterochromatin. Constitutive heterochromatin comprises 
repeat sequences and transposons which are obligatory silenced, whereas facultative 
heterochromatin contains genes (Trojer and Reinberg 2007). In contrast, euchromatic 
regions have higher accessibility and are enriched for active chromatin modifications 
(see 2.3). In the recent years, more detailed classifications have been proposed based 
on mapping of bound proteins and chromatin modifications (Filion et al, 2010; 
Kharchenko et al, 2011). 
In the following I will introduce the components and organization of chromatin together 
with their role in gene regulation. 
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2.2.1 Nucleosomes  
The nucleosome is the basic packaging unit of chromatin. This core subunit is formed 
when 146 basepairs of DNA are wrapped around an octamer of histone proteins in a 
1.65 turn (Luger et al, 1997). Contacts between negatively charged DNA and the basic 
histone proteins are stabilized through a number of electrostatic interactions, 
predominantly at the phosphodiester backbone. Importantly, due to the helix turn such 
interactions can only occur approximately every 10 base pairs. Histone octamers contain 
pairs of each of the histone proteins H2A, H2B, H3 and H4 which are placed by histone 
chaperones. These assemble a tetramer of (H3-H4)2 with two heterodimers of H2A-H2B 
(for review see (De Koning et al, 2007)). The canonical histone variants can alternatively 
also be replaced by relatively rare histone variants. For instance, histone H3.3 is 
deposited at active genes and was even proposed to transmit active epigenetic states 
(Ahmad and Henikoff 2002; Ng and Gurdon 2008b). Nucleosome core particles are 
connected by linker DNA (about 50-60bp in mammals) bound by a structural histone 
protein H1 that helps folding of nucleosome repeats to higher-order chromatin structures 
(Luger 2003).  
Beyond packaging of DNA, nucleosomes generally render the chromatin less 
permissive, so that their depletion can result in a 10-20 fold increased accessibility of 
DNA binding factors (Liu et al, 2006). Notably, recruitment of the transcriptional 
machinery by TATA-box binding protein as well as the binding of the general transcription 
factor TFIIIC requires a nucleosome-free environment (Workman and Kingston 1998; 
Bartke et al, 2010). This directly illustrates the inhibitory impact of nucleosomes on 
transcription initiation. It is clear, however, that binding ability of nucleosomal templates 
differs between TFs and not all are repulsed by the presence of nucleosomes (Taylor et 
al, 1991). Availability of a partner TF can increase the potential to access nucleosomal 
DNA, as in electrophoretic mobility shift assays some factors can only cooperatively 
achieve efficient binding to nucleosomal arrays (Adams and Workman 1995). On the 
other hand, even TFs which can bind to inaccessible chromatin on their own seem to 
prefer preexisting accessible sites (John et al, 2011). TFs without an inherent 
nucleosome binding capability can gain access to their cognate motifs with the help of 
“pioneer factors”, such as GATA-4 and FoxA1. These factors access nucleosome 
occupied DNA and can induce chromatin remodeling, thereby opening the chromatin for 
other proteins (Cirillo et al, 2002; Zaret and Carroll 2011). Finally, a group of transcription 
factors, including the pluripotency factors Oct4 or Nanog, seems to bind to nucleosome-
occupied regions without displacing the nucleosome (Teif et al, 2012).  
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Figure 2-2 Chromatin organization. Adapted from (Probst et al, 2009) 
2.2.2 Defining nucleosome positions 
In line with their role in gene regulation, nucleosomes are not randomly distributed 
throughout the genome, but instead well positioned at active regulatory regions (Yuan et 
al, 2005; Schones et al, 2008). Active promoters are characterized by a nucleosome-free 
region (NFR) in the vicinity of their TSS in all analyzed eukaryotes. Its size and the extent 
of nucleosome depletion both correlate with transcriptional output (Teif et al, 2012). CpG 
rich promoters are exceptional, as they possess an NFR even when inactive (Teif et al, 
2012). The first genome-wide nucleosome mapping was carried out in yeast (Yuan et al, 
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2005). In this model organism active promoter NFRs are typically flanked by strongly 
positioned nucleosomes at positions +1 and -1 and at least four additional well-
positioned nucleosomes downstream of the active TSS. The authors report a high 
conservation of nucleosome-free regions, suggesting that nucleosome depletion is a 
general feature of regulatory elements. Indeed, measurements of genome accessibility 
by DNAseI digestion suggest a high overlap of open chromatin regions with regulatory 
sites (Song L. et al, 2011). Recent accessibility and nucleosome positioning studies 
demonstrate that open chromatin at a given enhancer can occur independently of the 
presence of individual factors, even master regulators of cell fate (Teif et al, 2012; McKay 
and Lieb 2013). Such observations open up the possibility that distal regulatory elements 
can be “recycled” for usage by different TFs.  
Nucleosome positioning is nicely illustrated at insulator sequences bound by CTCF. A 
combinatorial profile shows that these are surrounded by 20 well-positioned 
nucleosomes (Fu et al, 2008). Importantly, in the absence of CTCF these sites tend to be 
occupied by a nucleosome, arguing that strong positioning is not encoded within the 
DNA sequence. Nucleosome phasing at these sites is furthermore recapitulated by a 
number of histone modifications (see 2.3.1) as well as by DNA methylation (Stadler et al, 
2011; Kelly et al, 2012) (see 2.4).  
Several lines of evidence suggest a role of DNA sequence in the positioning of 
nucleosomes (Struhl and Segal 2013). First, the repetitive nature of nucleosomes 
excludes contributions of highly specific sequences and thus a favoring sequence would 
simply be one that favors bending of DNA. From analysis of genomic DNA from chicken 
erythrocytes, it has been suggested that this is given in case of a ten-base periodic 
occurrence of AT, allowing helical bending around the histones (Satchwell et al, 1986). 
Indeed, the prevalence of such periodicity is increased at well-positioned nucleosomes in 
the yeast genome (Ioshikhes et al, 2006). Second, long stretches of dA:dT or dG:dC 
polymers, such as those present at many eukaryotic promoters, disfavor bending of 
DNA, thus providing a plausible explanation for nucleosome depletion at the TSS 
(Simpson and Shindo 1979). This does not seem a universal principle, as several yeast 
strains are capable of establishing promoter NFRs without having enrichments of 
monopolymer stretches (Tsankov et al, 2010). Third, in vitro reconstituted nucleosomes 
overall manage to recapitulate in vivo positioning of the yeast chromatin (Kaplan et al, 
2009; Zhang et al, 2009).  
While in vitro reconstitution experiments allow for a recapitulation of nucleosome-
depleted sites, positioning of the nucleosomes at positions +1 and -1 can only be 
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achieved upon addition of ATP and a crude cell extract (Zhang et al, 2011). Thus, precise 
positioning of the TSS flanking nucleosomes cannot be solely guided by the DNA 
sequence. At the same time, exact positions of all nucleosomes are not reproduced in 
any of the in vitro assays (Zhang et al, 2011). In summary, these experiments argue that 
DNA sequence in cooperation with ATP dependent and independent factors present in 
the cell extract determines the positioning of nucleosomes around NFRs.  
Nucleosomes are indeed reordered by specialized ATPases. (Clapier and Cairns 2009; 
Mueller-Planitz et al, 2013). Currently, four families of these nucleosome remodelers are 
known: SWI/SNF, ISWI, CHD and INO80 which are conserved between eukaryotes from 
yeast to humans. These families have different functions in assembly or disassembly of 
entire nucleosomes, whereas all of them seem to be capable of nucleosome dislocation. 
Mechanistically, this can be achieved by a localized destabilization of histone-DNA 
interactions as well as by destabilization of the DNA or of the histone octamer (reviewed 
in (Mueller-Planitz et al, 2013)). Furthermore, remodelers can display specialized 
functions in promoter activation and repression. This is exemplified in yeast, where the 
RSC remodeling complex is involved in nucleosome removal from promoter regions 
(Badis et al, 2008; Wippo et al, 2011). Conversely, the activity of Isw2 is needed to 
occlude nucleosome disfavoring promoter regions (Whitehouse and Tsukiyama 2006). 
Recent mapping of nucleosome remodelers in mouse cells suggests a highly 
overlapping synergistic as well as antagonistic function between different complexes 
(Morris et al, 2014). Targeting of remodelers is possible through specific recognition 
sequences (Badis et al, 2008), binding to nucleosomes and histone modifications or 
recruitment by specific TFs. As an example, at yeast HO promoter the SWI/SNF complex 
is recruited upon binding of the transcription factor Swi5p. This enables histone 
acetylation through the SAGA complex and ultimately binding of SBF (Cosma et al, 
1999).  
It is not entirely clear, how positioning is regulated within the gene bodies. It has been 
speculated that elongating RNA polymerase II has a function in the positioning of 
nucleosome arrays downstream of the TSS (Struhl and Segal 2013). In support of this 
hypothesis, nucleosome remodelers bind to coding regions (Morris et al, 2014). It is 
furthermore conceivable that a histone passback mechanism during active transcription 
affects nucleosome organization (Radman-Livaja et al, 2011).  
In the last years it became clear that nucleosomes themselves are not stable structures, 
but instead underlie a dynamic turnover (Ahmad and Henikoff 2002). Replication 
independent turnover was studied in G1 arrested yeast by competition between 
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constitutively expressed and inducible histones (Dion et al, 2007; Jamai et al, 2007; 
Rufiange et al, 2007). These experiments suggested a turnover of histone H3, H4 and 
H2B at promoters. High histone dynamics at sites containing epigenetic modifications 
was later indentified and quantified by a technique utilizing metabolic posttranslational 
histone labeling (Deal et al, 2010).  
 
 
Figure 2-3 Model of nucleosome positioning. Adapted from (Struhl and Segal 2013) 
Note that the here suggested model is based on yeast data. (A) Nucleosome depleted regions 
(NDR) are determined either by sequence polymer stretches and/or by transcription factors and 
recruited remodelers. Gray circles: nucleosomes (B) Preferred positions (black circles) of NDR-
flanking nucleosomes are regulated by remodelers and pre-initiation complex (PIC). (C) 
Positioning of nucleosomes downstream of the TSS depends on elongation by RNA polymerase II 
(PolII) and elongation-associated remodeler complexes.  
Nucleosome positioning and stability have been linked to chromatin modifications by 
several studies. It has been reported that histone acetylation (see 2.3) is a positive 
regulator of turnover (Rufiange et al, 2007; Verzijlbergen et al, 2011). Furthermore, DNA 
methylation has been implicated in stabilizing histone-DNA interactions (Collings et al, 
2013) However, a simultaneous genome-wide mapping of nucleosome positioning and 
DNA methylation showed an anticorrelation of DNA methylation and nucleosome 
occupancy around CTCF sites (Kelly et al, 2012).  
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2.3 Chromatin modifications  
Chromatin modifications are chemical groups covalently coupled to either DNA or 
histone proteins, the “epigenetic modifications”. In the original definition by Waddington 
1942, the term “epigenetics” was applied to mechanisms which generate a phenotype 
from a genotype (republished in (Waddington 2012)). Later, this definition was extended 
to heritable changes in gene expression not involving alterations of the genomic 
sequence (Allis 2007).  
Indeed, epigenetic modifications might fulfill these criteria as they possess gene-
regulatory potential either directly by controlling the accessibility of chromatin through 
electric charges or indirectly by recruiting additional “readers” of the respective 
modification (Bannister and Kouzarides 2011). Mechanisms of inheritance and self-
propagation have been proposed for DNA methylation, repressive and histone variant 
coupled active modifications (Okano et al, 1998; Ng and Gurdon 2008a; Probst et al, 
2009). However, a mechanism for replicative transmission has not been described for all 
chromatin modifications. Transgenerational inheritance is even more questionable, since 
epigenetic marks can be removed during gametogenesis and development (Reik 2007).  
These limitations are corrected in a third definition of epigenetics, made by Adrian Bird 
(Bird 2007). He proposed epigenetics to be “the structural adaptation of chromosomal 
regions so as to register, signal or perpetuate altered activity states”. Since this definition 
includes all chromatin-based processes it appears as the most unifying and 
contemporary compared to the definitions discussed above.  
In the last two parts of the introduction I will discuss epigenetic modifications in light of 
their regulatory potential and stability.  
2.3.1 Histone modifications 
Histones can bear various posttranslational modifications (PTMs) either within their 
globular domains or at their N-terminal tails (Izzo and Schneider 2010). Structurally, 
histone tails are protruding from the octamer, suggesting that their modifications may 
have an increased potential to contribute to the overall stability of a nucleosome (Luger 
et al, 1997). Such modifications can be acetylation, methylation, phosphorylation, 
ubiquitinylation and ADP-ribosylation, with activating or repressive functions (Bannister 
and Kouzarides 2011). Combinatorial spatial or temporal activity of distinct modifications 
has been proposed to form a “histone code” (Strahl and Allis 2000).  
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The oldest example of how histone modifications can influence gene expression comes 
from a pioneering study demonstrating the posttranslational nature of acetylation and 
methylation of histone residues (Allfrey et al, 1964). Based on in vitro transcription in the 
presence of acetylated histones, Allfrey et al. show that the inhibitory effect of histones 
on RNA synthesis is decreased upon their acetylation despite preserved DNA binding 
capacity. They suggested that positively charged acetylated lysines partially disrupt 
histone-DNA interactions. In agreement with this hypothesis, lysine acetylation overlaps 
with active gene regulatory elements (Heintzman et al, 2007; Heintzman et al, 2009). 
Furthermore, histone acetyltransferases, such as the yeast protein Gcn5, have been 
linked to gene activation (Brownell and Allis 1996; Brownell et al, 1996). Consequently, 
inhibition of histone deacetylases enhances somatic cell reprogramming by a factor of 
1000 (Huangfu et al, 2008). Histone acetylation can furthermore disrupt higher-order 
chromatin structure as has been demonstrated in vitro for nucleosomal arrays containing 
lysine 16 acetylation of histone H4 (Shogren-Knaak et al, 2006). 
Contrary to acetylation, methylation (usually occurring at lysines or arginines) does not 
affect the charge of the histone proteins and thus can be activating or repressive 
dependent on the context (Bannister and Kouzarides 2011). A canonical example for a 
methylated residue associated with active state is lysine 4 of histone H3 (H3K4). 
Trimethylation typically occurs at the promoters of all active genes in a well-conserved 
manner among eukaryotes (Heintzman et al, 2007; Heintzman et al, 2009). Several 
chromatin remodeling complexes and histone acetyltransferases can read H3K4 
methylation. Together with the evidence that the general transcription factor TFIID can 
bind H3K4me3 through its PHD domain this suggests a direct involvement of this mark in 
regulating transcriptional initiation at promoters (Santos-Rosa et al, 2003; Taverna et al, 
2006; Vermeulen et al, 2007). There is furthermore experimental evidence that 
transcriptional activity directly affects the level of H3K4me3 at promoters in yeast, where 
the H3K4 methyltransferase SET1 is recruited by elongating RNA polymerase II (Krogan 
et al, 2003; Ng et al, 2003). In addition to active promoters, H3K4me3 decorates all CpG 
island promoters (see 2.4) independently of their activity but only in the absence of DNA 
methylation. This suggests a general recruitment to CpG-rich regions which might be 
achieved through binding of the zinc finger CXXC domain containing protein CFP1. 
CFP1 coexists in a complex with SETD1 H3K4 methyltransferase and was demonstrated 
to recruit H3K4me3 to an exogenous CpG island independently of transcription 
(Thomson et al, 2010). 
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In contrast to H3K4me3, polycomb mediated lysine 27 trimethylation of histone H3 
(H3K27me3) has been widely associated with repression of developmental genes 
(Ringrose and Paro 2004; Mohn et al, 2008). Similarly to H3K4me3, H3K27me3 is 
enriched at CpG islands and its targeting to CpG-rich regions was proposed to depend 
on transcriptional inactivity (Mendenhall et al, 2010; Lynch et al, 2012). In Drosophila, 
polycomb targeting has been well described and is determined by sequences called 
polycomb response elements (PREs). In mammals several different mechanisms have 
been proposed, including recruitment by long noncoding RNAs or transcription factors 
(Ringrose and Paro 2004; Tsai et al, 2010; Arnold et al, 2013).  
Genome-wide mapping of histone modifications suggests their highly characteristic 
distribution at cis-regulatory elements (Heintzman et al, 2007; Heintzman et al, 2009). In 
human cell lines active promoters are invariantly marked by H3K4me3 and histone 
acetylation and these marks are conserved across cell types. Enhancer landscape is 
more dynamic with high ratio of H3K4me1:H3K4me3 and H3K27 acetylation as the most 
characteristic signatures of activity. Importantly, these landscapes are so specific that 
they can be used for de novo prediction of enhancers (Heintzman et al, 2007).  
Besides the previously mentioned direct influence on chromatin structure, histone 
modifications can affect binding of effector proteins (Bartke et al, 2010). These can be 
sequence-specific transcription factors or unspecific binders, such as chromatin 
remodeling complexes. 
Influence of histone modifications on gene regulation at enhancers can be exemplified by 
the pioneer transcription factor FoxA1 (Lupien et al, 2008). Genome-wide mapping of 
FoxA1 binding sites in two human cancer cell lines shows a correlation with H3K4me1 
and H3K4me2. Importantly, depletion of H3K4 dimethylation by overexpression of the 
histone methyltransferases LSD1 disrupts FoxA1 binding, suggesting a role of H3K4 
methylation in FoxA1 recruitment. At the same time, H3K4 methylation does not seem to 
be the sole determinant of FoxA1 binding, as FoxA1 also occupies sites lacking 
H3K4me1/2 when overexpressed in a cancer cell line (Serandour et al, 2011).  
Impact of TF binding on epigenetic landscapes can be illustrated in macrophage 
differentiation. In this system Egr-2 reduces H3K4me3 levels at the miR-17-92 promoter 
through recruitment of the demethylase Jarid1b (Pospisil et al, 2011).  
Today it is evident that histone modifications regulate gene expression as part of highly 
coordinated events, where multiple effectors and pathways act in close collaboration to 
provide functional output (Cosma et al, 1999; Li et al, 2010). 
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Figure 2-4 Posttranslational histone modifications. Adapted from (Bhaumik et al, 2007). 
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2.4 DNA methylation 
Together with its derivatives DNA methylation is the only known covalent modification of 
DNA. Participation of DNA methylation in inheritance of epigenetic states as well as its 
role in repression of genes has been proposed as early as in 1975 (Holliday and Pugh 
1975; Riggs 1975). Since then it became increasingly appreciated that DNA methylation 
correlates with gene repression, although a causal role appears to depend on the 
genomic context (Baubec and Schübeler, in press). More accepted is the function of 
DNA methylation in such fundamental processes like X-chromosome inactivation, 
imprinting and repeat silencing (Goll and Bestor 2005). It is furthermore essential for 
differentiation and development and consequently abnormal methylation patterns can be 
found in cancer and disease (Shirohzu et al, 2002; Plass et al, 2013).  
In the following paragraphs, I will summarize current knowledge about this epigenetic 
mark with an emphasis on stability and regulatory function. 
2.4.1 Evolution of DNA methylation 
DNA methylation has been proposed to originate from the primitive prokaryotic immune 
system (Bestor 1990). Indeed, bacteria use methylation of adenine or cytosine in host 
defense for selective destruction of exogenous bacteriophage DNA (Goll and Bestor 
2005). Such defense mechanism, however, has never been reported in eukaryotes.  
While the genome of some lower eukaryotes contains methylated adenines (Gorovsky et 
al, 1973), in higher eukaryotes DNA methylation occurs exclusively at the fifth carbon of 
cytosines (5-methylcytosine, 5mC) (Wyatt 1951; Bird and Wolffe 1999; Goll and Bestor 
2005). This modification is common to organisms with large genomes, suggesting that 
DNA methylation evolved as an additional regulatory layer to compensate for the 
increased genomic complexity (Bestor 1990). Thus, necessity to silence transposons 
combined with sexual reproduction has been proposed as the major driving force for the 
evolution of DNA methylation (Zemach and Zilberman 2010). 
In the fungus Neurospora crassa, DNA methylation almost exclusively affects relics of 
transposons which were subject to repeat-induced point mutations as part of a genome 
defense mechanism (Selker et al, 2003). While this pattern is conserved among other 
fungal species with DNA methylation, the sequence context of methylated cytosines can 
vary (Zemach et al, 2010). Importantly, the most widely studied model fungi 
Saccharomyces cerevisiae and Saccharomyces pombe both lack DNA methylation.  
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In contrast to fungi, methylation in the plant Arabidopsis thaliana localizes not only to 
transposons but also to gene bodies and repetitive elements (Zhang et al, 2006). In this 
species cytosine methylation occurs in the context of CHH, CHG and CG sequences 
with an overall relatively small fraction (up to 25%) of methylated cytosines (Furner and 
Matzke 2011). Importantly, transposon and repeat upregulation in DNA methylation 
mutants suggest that their silencing might indeed be the key role of DNA methylation in 
plants (Zilberman et al, 2007; Lister et al, 2008; Tsukahara et al, 2009).  
While DNA methylation is common to all vertebrate genomes, its prevalence is limited 
among non-vertebrate animals. The genomes of Drosophila melanogaster and 
Caenorhabditis elegans both are devoid of DNA methylation. Non-vertebrate animals 
with DNA methylation – such as the honeybee Apis mellifera – show incomplete mosaic 
or “fractional” methylation with moderate methylation levels, mostly within gene bodies 
(Zemach et al, 2010; Deaton and Bird 2011). The transition to vertebrate lineages was 
accompanied by the acquisition of genome-wide DNA methylation (Tweedie et al, 1997; 
Deaton and Bird 2011). Here, methyl groups predominantly occur in the context of CpG 
dinucleotides, although rare cases of cytosine methylation in a non-CpG context have 
been reported in stem cells and brain tissue (Ramsahoye et al, 2000; Lister et al, 2009; 
Lister et al, 2013). Genome-wide DNA methylation brought up the hypothesis that 
vertebrate genomes are methylated by default and targeted demethylation is the key 
regulatory mechanism (Bird and Wolffe 1999). In summary, methylation differs between 
eukaryotic lineages in terms of preferences for sequence contexts and spatial 
distribution.  
In their comparative study of methylomes from a variety of species Zemach et al. 
suggested that the last common ancestor of plants, fungi and vertebrates possessed all 
tools of the DNA methylation machinery (Zemach et al, 2010). If this hypothesis is true, 
then DNA methylation has been lost in several lineages, such as in D. melanogaster and 
C. elegans (Dean et al, 2001; Suzuki and Bird 2008). This could be enabled partially due 
to the lack of selective pressure and partially because other compensatory mechanisms 
have evolved (Brennecke et al, 2007). Loss of DNA methylation in some lineages argues 
that it might have opposing effects on the fitness of an organism (Hollister and Gaut 
2009; Zemach et al, 2010). Genome-wide DNA methylation in vertebrates might indeed 
have evolved as a silencing mechanism for transposons and repeats. Following this, 
their occasional insertion in introns could have spread the methylation over the coding 
gene regions (Jahner and Jaenisch 1985). In this case, the benefits of preserving the 
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genome’s stability by transposon inactivation must have outperformed the potential 
disadvantages of aberrant gene silencing.  
2.4.2 DNA methylation patterns in vertebrates 
Genome-wide methylation patterns in vertebrates are mainly established during 
gametogenesis and postimplantation development following global demethylation 
(Morgan et al, 2005; Borgel et al, 2010). During gametogenesis parental imprint 
methylation is reestablished which later resists global demethylation upon fertilization of 
the oocyte (Tucker et al, 1996; Dean et al, 2001). Further programmed methylation takes 
place during development and differentiation and affects somatic imprints and gene 
promoters (Mohn et al, 2008; Borgel et al, 2010). 
In general, the majority of cytosines in the context of CpG dinucleotides (about 80%) are 
methylated, thus allowing DNA methylation to extend its function beyond silencing of 
transposons (Lister et al, 2009; Zemach et al, 2010; Deaton and Bird 2011; Long et al, 
2013b). Since methylated cytosines are predisposed to deamination, germline mutations 
render mammalian genomes globally depleted in CpGs (Coulondre et al, 1978; Bird 
1980; Schorderet and Gartler 1992; Freitag et al, 2002; Zemach et al, 2010). A notable 
exception are CpG islands (CGI) with a locally high concentration of CpG dinucleotides 
(ration observed/expected >0.5 dependent on the algorithm) (Bird et al, 1985). About 
70% of genes contain a CGI in their promoter and only about 3% of those become 
methylated in adult tissues (Deaton and Bird 2011; Long et al, 2013b). Thus, while 
methylation of CpG island promoters usually coincides with gene silencing, most of them 
remain unmethylated but inactive (Stein et al, 1982; Schilling and Rehli 2007; Shen et al, 
2007; Weber et al, 2007; Mohn et al, 2008; Payer and Lee 2008). Promoters are 
furthermore frequently silenced by other epigenetic marks before acquiring DNA 
methylation (Feldman et al, 2006). Taken together these observations led to the 
speculation that DNA methylation has a role in “locking-in” the repressive state of genes 
and thus is required wherever stable silencing is needed. 
A variety of methods have been developed for the analysis of unmethylated or 
methylated DNA. These include endonuclease digestion by enzymes with different 
sensitivity towards DNA methylation (Bird and Southern 1978), affinity purification of 
methylated or unmethylated DNA (Cross et al, 1994; Weber et al, 2005; Blackledge et al, 
2012) and conversion of unmethylated cytosines to uracil by bisulfite treatment (Wang et 
al, 1980; Frommer et al, 1992). The latter method allows for a single base resolution 
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global methylation analysis when coupled with genome-wide sequencing technologies 
and was recently applied by several groups to mammalian genomes (Lister et al, 2009; 
Hodges et al, 2011; Stadler et al, 2011; Xie et al, 2013; Ziller et al, 2013). These studies 
revealed that the genome-wide methylation landscape is characterized by segment-
specific methylation signatures with more or less uniformly methylated blocks. In 
agreement with previous observations, the majority of cytosines indeed fall into fully 
methylated or unmethylated regions (FMRs and UMRs, respectively). In this 
classification UMRs largely correspond to unmethylated CpG islands (Lister et al, 2009; 
Stadler et al, 2011).  
 
 
Figure 2-5 Schematic representation of DNA methylation landscape in vertebrates.  
Three major segment types are shown as defined in Stadler et al. (Stadler et al, 2011): Fully 
methylated regions (FMR, blue) with mostly 80-100% methylated CpGs, unmethylated regions 
(UMR, green) with methylation ranging from 0 to 10% and low methylated regions (LMR, red) with 
about 10-50% methylation. Grey shadows represent the variability in methylation between 
individual cytosines. CpG density (black, dashed line) is elevated at UMRs which mostly 
correspond to CpG islands and to a lower extent at LMRs. DNAseI cuts in UMRs and LMRs, 
indicative of an open chromatin state and transcription factor presence within these regions. 
LMRs are marked by low H3K4me3 and high H3K4me1, characteristic for enhancers. 
However, in addition to these previously anticipated domains, a new class of low CpG-
density segments has been identified which is hypomethylated but not fully unmethylated 
like CpG islands and therefore termed low methylated regions or LMRs (Stadler et al, 
2011). Average methylation within these regions comprises 30%, although the 
methylation state of individual cytosines can vary throughout the domain. Importantly, 
LMRs possess all features of active distal regulatory elements with enrichments of cell 
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type specific DNA-binding factors and enhancer-characteristic histone marks. 
Furthermore, insertion of unmethylated or in vitro methylated DNA fragments at an 
ectopic locus in mouse embryonic stem cells showed that binding of the factor CTCF is 
necessary and sufficient for creating a hypomethylated state. This observation argues 
against an instructive role of DNA methylation for transcription factor recruitment to these 
regions. Importantly, methylation at LMRs changes dynamically during neuronal 
differentiation correlating with changes in the expression of cell type specific TFs and 
with active enhancer signatures. The presence of low methylated regions has been 
described in many cell types, confirming these initial findings in embryonic stem cells 
(Hodges et al, 2011; Stadler et al, 2011; Burger et al, 2013; Hon et al, 2013; Xie et al, 
2013; Jeong et al, 2014).  
More recent global studies on DNA methylation in human ES cell differentiation and 
hematopoietic stem cells reported presence of methylation depleted regions exceeding 
the size of LMRs or UMRs (median in ES cells 324bp and 581bp, respectively) by 
several fold (median size: >5kb). These regions were termed methylation “valleys” or 
“canyons” (Xie et al, 2013; Jeong et al, 2014). Besides the difference in size they largely 
resemble CpG islands, cover conserved motif-rich sequences and are conserved 
between cell lineages. Interestingly, loss of the DNA methyltransferases DNMT3A 
mediated DNA methylation increases the size of canyons, suggesting a role of DNA 
methylation turnover in the maintenance of border methylation at these regions (Jeong et 
al, 2014). Regulatory potential of unmethylated and hypomethylated sequences is further 
demonstrated by a recent study showing evolutionary conservation of hypomethylated 
regions between vertebrate species (Long et al, 2013a).  
Beyond these segments with well-defined methylation states, large partially methylated 
domains (PMD) with apparently deregulated variable methylation are detectable in some 
mammalian cell types (Lister et al, 2009; Gaidatzis et al, 2014). 
2.4.3 DNA methylation machinery 
Methyl groups are added to cytosines in an S-Adenosyl-Methionine (SAM) dependent 
reaction by a conserved group of enzymes called DNA methyltransferases (DNMTs). In 
their speculative pioneer work Holliday and Pugh predicted the presence of two enzyme 
activities to maintain a cell’s methylation levels: a de novo methyltransferase and a 
maintenance methyltransferase (Holliday and Pugh 1975). The maintenance enzyme 
was predicted to share the capacity of bacterial methyltransferases to act only on 
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hemimethylated DNA and thereby copy methylation to the palindromic CpG sequence of 
the daughter cell. This traditional separation into maintenance and de novo methylating 
enzymes remains in use today. 
As originally postulated, the maintenance DNA methyltransferase DNMT1 prefers 
hemimethylated DNA as substrate (Stein et al, 1982; Bestor et al, 1988; Okano et al, 
1998). Initial in vitro methylation assays (Okano et al, 1998) found confirmation in the 
structural analysis showing autoinhibition of DNMT1 catalytic center upon binding of a 
fully unmethylated substrate DNA (Song J. et al, 2011; Song et al, 2012). DNMT1 is 
recruited to the replication forks by UHRF1, a protein which interacts with PCNA during 
DNA synthesis (Sharif et al, 2007). Such maintenance provides a potential mechanism 
for epigenetic memory and inheritance (Holliday and Pugh 1975; Riggs 1975). Indeed, 
methylation at CGIs is accurately transmitted, as has been demonstrated by integration 
of premethylated DNA fragments (Wigler et al, 1981; Schubeler et al, 2000). Certain 
sequences, however, can autonomously determine their methylation state independently 
of preceding manipulation (Lienert et al, 2011; Stadler et al, 2011).  
Lei et al. reported the first experimental evidence that mammals possess separate 
enzymes for the catalysis of de novo DNA methylation in 1996, when they noticed that 
proviral DNA can be de novo methylated in the absence of DNMT1 (Lei et al, 1996). The 
de novo DNA methyltransferases DNMT3A and DNMT3B were cloned and characterized 
a few years later, confirming that they indeed are able to methylate unmodified cytosines 
(Okano et al, 1998; Okano et al, 1999).  
 
 
Figure 2-6 Schematic representation of de novo and maintenance DNA methylation 
Methylated CpG: black lollipops, unmethylated CpG: white lollipops 
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Although common consent accepts this role distribution, it is probably not very accurate. 
For example, the in vitro de novo methylation activity of DNMT1 is five times higher than 
that of DNMT3A/B (Okano et al, 1998). Similarly, DNMT3A/B possess maintenance 
activity in vitro (Okano et al, 1998) and in vivo, as deletion of DNMT1 in embryonic stem 
cells does not result in complete loss of methylation (Lei et al, 1996; Jackson et al, 
2004). There is furthermore evidence that de novo DNA methyltransferases participate in 
local or global methylation maintenance in vivo (Chen et al, 2003; Jackson et al, 2004; 
Arand et al, 2012; Jeong et al, 2014). Initially, nearest-neighbor analysis suggested a 
progressive loss of methylation in DNMT3A/B double-knockout embryonic stem cells, 
resulting in a global methylation decrease by 50% at passage 20 upon knockout 
(Jackson et al, 2004). Arand et al. found varying dependency of genomic regions on 
DNMT3A/B for methylation maintenance when they analyzed methylation of DNMT 
mutant mouse ES cell lines by hairpin-bisulfite PCR (Arand et al, 2012). For instance, 
methylation at Tex13, Afp, IAPs and mSat can be maintained by either enzyme, while 
Igf2, Snrpn, B1 and L1 repeats require cooperativity from both enzymes. Surprisingly, 
these characteristics differ from one region to another and no common rule distinguishes 
between single genes and repetitive sequences.  
Analysis of DNMT3A and DNMT3B knockout mice and embryonic stem cell lines 
revealed target specificity of de novo DNA methyltransferases (Okano et al, 1999). For 
instance, centromeric minor, but not major satellite repeats are hypomethylated in both 
DNMT3B knockout and hypomorphic mutant mice (Okano et al, 1999; Velasco et al, 
2010). How exactly DNMT3A/B are targeted to specific loci remains to be determined. 
Contribution of flanking sequences to targeting specificity of DNMTs has been reported 
(Lin et al, 2002; Handa and Jeltsch 2005; Gowher et al, 2006) as well as recruitment by 
transcription factors, such as E2F6 (Velasco et al, 2010). DNMT3A/B have been shown 
to anchor to methylated nucleosomes in cancer cell lines (Jeong et al, 2009).  
DNMTs are differentially expressed throughout development and cell differentiation 
(Okano et al, 1998; Okano et al, 1999; La Salle et al, 2004; Watanabe et al, 2006). 
DNMT3B expression is widespread in the early embryo and is restricted mostly to the 
developing brain upon embryonic day E9.5, the time-point when DNMT3A expression 
becomes ubiquitous (Okano et al, 1999). DNMT3A functions predominantly in germ cells 
as the main methyltransferase in the establishment of parental imprints and is moreover 
upregulated later in development (Watanabe et al, 2006; Nguyen et al, 2007; Challen et 
al, 2012). Different temporal and spatial expression patterns are mirrored in the 
phenotypes of knockout mice (Okano et al, 1999). In general, knockout of any enzymatic 
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DNMT is lethal. However, while DNMT3B and DNMT1 knockout mice die during 
embryogenesis, DNMT3A knockout animals survive until 4 weeks after birth. A role of 
DNMT3A in postnatal cells has been described for hematopoietic stem cell differentiation 
upon conditional knockout (Challen et al, 2012). The authors used bone-marrow 
transplanted conditional knockout hematopoietic stem cells to track their in vivo 
differentiation potential. They found that the differentiation was compromised and the 
cells were biased towards the stem cell state. Unexpectedly, reduced-representation 
bisulfite sequencing revealed equal amounts of both demethylated and hypermethylated 
regions upon DNMT3A knockout and little correlation to gene expression changes. 
It seems that the presence of DNMTs is overall dispensable for embryonic stem cells. ES 
cells lacking all three DNMTs are viable and even retain the differentiation capability to 
embryonic lineages as long as DNMT1 is present (Jackson et al, 2004; Tsumura et al, 
2006). Survival of extraembryonic lineages, on the other hand, appears independent of 
DNA methylation (Sakaue et al, 2010).  
Even though in general DNMTs are downregulated upon development and 
differentiation, notable amounts can still be detected in adult postmitotic cells (Goto et al, 
1994). However, the molecular function of DNMTs in adult tissues is not well understood. 
For example, Nguyen et al. demonstrated neuromuscular defects in a conditional 
knockout of DNMT3A in mouse neurons (Nguyen et al, 2007). Only very limited 
demethylation was detected at one of the investigated gene promoters in the adult 
mouse brain. This subtle effect does not allow establishing a link between observed 
defects and the methyltransferase activity of DNMT3A. Other studies suggest a role of 
DNA methylation in neuronal activity, although the link between DNA methylation, gene 
expression and reported defects remains unexplained (Feng et al, 2010; LaPlant et al, 
2010; Guo et al, 2011b). 
Together with conditional knockout experiments, presence of the DNA methylation 
machinery in adult cells argues that maintaining plasticity of DNA methylation might be 
important beyond development and differentiation (Feng et al, 2010; Guo et al, 2011b). 
The task of the DNA methyltransferases in differentiated tissues could involve correction 
of DNA damage, maintenance of transcriptional silencing capacity or participation in 
turnover.  
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2.4.4 DNA demethylation 
2.4.4.1 Passive and active demethylation 
Because of its heritability, its covalent coupling to DNA and the stability of the C-C bond 
between the fifth carbon of the cytosine and the methyl group, DNA methylation has 
been considered a stable modification whose main function is to ensure long-term 
silencing (Wu and Zhang 2010). Insights from developmental studies, however, suggest 
that it is more dynamic than anticipated. In mammalian development DNA methylation is 
removed in two main waves: during gametogenesis and preimplantation (Mayer et al, 
2000; Oswald et al, 2000; Hajkova et al, 2002; Lee et al, 2002; Santos et al, 2002; 
Yamazaki et al, 2003; Wu and Zhang 2010; Seisenberger et al, 2013). Interestingly, 
during zygotic demethylation maternal and paternal pronuclei seem to rely on different 
demethylation mechanisms. Paternal pronucleus undergoes rapid demethylation, 
whereas the maternal pronucleus gradually loses its methyl mark. This difference in 
kinetics probably exemplifies active and passive demethylation.  
Passive demethylation occurs when replication dependent maintenance is compromised. 
This can be mediated by exclusion of DNMT1 from the nucleus, as reported for 
preimplantation development (Monk et al, 1987; Howlett and Reik 1991; Carlson et al, 
1992), or protection of DNA from the maintenance machinery (Hsieh 1999).  
On the other hand, active demethylation requires a mechanism that catalyzes removal of 
the methyl group (Wu and Zhang 2010). In case of zygotic development, demethylation 
of the paternal pronucleus coincides with oxidation of 5-methylcytosine to 5-
hydroxymethylcytosine (see 2.4.4.4). During these events the maternal pronucleus is 
most likely protected from active demethylation by Stella/DPPA3 (Gu et al, 2011; 
Wossidlo et al, 2011). The possibility of active demethylation causes a lot of excitement 
as it would allow for increased plasticity in gene regulation (Bird 2002). Nevertheless, 
while the presence of active demethylation has been widely accepted, the field suffers 
from unclarity in mechanisms. 
The main challenge in the field is distinguishing between passive and active 
demethylation. This can be achieved by excluding replication mediated effects as is the 
case for demethylation of paternal pronucleus. Furthermore, active demethylation implies 
selectivity, so that it should be site-specific. Multiple studies report occurrence of local 
demethylation during differentiation of dividing (Mohn et al, 2008; Stadler et al, 2011; 
Serandour et al, 2012) or post-mitotic (Klug et al, 2010) cells. Active demethylation has 
also been reported in postmitotic neurons upon induction of neuronal activity in vitro at 
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the Bdnf promoter (Martinowich et al, 2003) and in vivo using genome-wide mapping of 
methylation-sensitive restriction sites (Guo et al, 2011b). However, overall demethylation 
in these systems was low and limited to individual cytosines within a few regions.  
Other reports suggest a connection between demethylation and transcriptional activity at 
promoters (Kangaspeska et al, 2008; Metivier et al, 2008) or enhancers (Stadler et al, 
2011; Wiench et al, 2011; Shen et al, 2013; Song et al, 2013). This hypothesis points 
directly to the question of whether DNA methylation is instructive for gene activity at all.  
Mechanisms suggested to regulate active demethylation can generally be subdivided 
into three different categories: direct demethylation, targeted DNA repair and oxidation 
mediated demethylation (Franchini et al, 2012). In many cases a combination of different 
mechanisms is possible. 
2.4.4.2 Direct removal of the methyl group 
Direct removal of 5-methylcytosine is considered as chemically challenging, since it 
would require a direct cleavage of the C-C bond between the cytosine and the methyl 
group (Wu and Zhang 2010; Franchini et al, 2012). Direct demethylation has never been 
reported in vivo. However, in an in vitro assay all three mammalian DNMTs have been 
proposed to act as direct demethylases in the presence of Ca2+ and absence of the 
methyl group donor S-Adenosyl-Methionine (Chen et al, 2013a).  
2.4.4.3 Targeted DNA repair 
DNA repair mediated active demethylation pathways involve glycosylation and 
deamination of 5mC followed by base-excision repair (BER).  
Glycosylation mediated demethylation is indeed known from plants, where it is executed 
by the Demeter family of DNA glycosylases (Gehring et al, 2009). A mammalian 
glycosylase suggested to participate in active demethylation is the T DNA glycosylase 
TDG (Zhu et al, 2000). Its homologue has initially been purified from chicken embryo 
extracts as demethylating enzyme which prefers hemimethylated over bi-stranded 
methylated or unmethylated DNA as substrate (Jost 1993). Quantification of its catalytic 
activity revealed that it is considerably higher at mismatched G/T than at 5mC (Zhu et al, 
2000). TDG has been recently implicated in oxidation mediated demethylation pathways 
(He et al, 2011) (see 2.4.4.4).  
Deamination followed by BER appears to be a mechanism more suitable for the activity 
of TDG, as deamination of 5mC creates its preferred substrate, the T/G mismatch. The 
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main deaminases implicated in active demethylation are the activation-induced 
deaminase AID and the family of apolipoprotein B mRNA editing enzyme catalytic 
polypeptide proteins (APOBEC) (Morgan et al, 2004). Mice deficient for AID have mildly 
increased methylation in primordial germ cells (Popp et al, 2010). However, the 
difference to wild type animals is so small that AID is most likely not the major 
demethylase in the germline. 
Both mechanisms require targeted lesion of DNA in order to act at specific sites and it 
has been reported that AID catalyzes site-specific demethylation (Bhutani et al, 2010). It 
is unclear, however, how such targeting might be achieved in the absence of a DNA 
binding domain.  
2.4.4.4 Oxidation mediated demethylation 
TET proteins 
In the last years, most mechanisms postulated to play a role in active demethylation 
involve oxidation of 5-methylcytosine to 5-hydroxymethylcytosine (5hmC) by the TET 
family proteins (Wyatt and Cohen 1953; Kriaucionis and Heintz 2009; Tahiliani et al, 
2009). The discovery of TET proteins was inspired by a search for mammalian 
homologues of J-binding proteins JBP. JBP contribute to the generation of the “base J” 
by oxidation of the methyl group of a modified thymine in Trypanosoma brucei (Tahiliani 
et al, 2009). At the moment three proteins of this family of Fe2+- and 2-oxoglutarate 
dependent dioxygenases are known: TET1, TET2 and TET3 (Ito et al, 2010). All of them 
share a homologous C-terminal domain with a capacity to convert 5mC in 5hmC. In 
contrast to TET2, TET1 and TET3 both contain a CXXC domain which guides their 
binding to CpG islands (Xu et al, 2011; Xu et al, 2012). Thus, it is likely that different 
family members have distinct substrate specificities, as suggested in a recent profiling of 
hydroxymethylation in TET1 and TET2 knockdown embryonic stem cells (Huang et al, 
2014). 
Evidence that TET proteins are involved in active DNA demethylation first came from in 
vitro and over-expression studies (Guo et al, 2011a; He et al, 2011; Ito et al, 2011). 
Recent tethering of TET1 to a specific locus showed that its catalytic activity only leads 
to a minor and locally defined loss of methylation (Maeder et al, 2013). Simultaneous 
knockout of TET1 and TET2 proteins, however, increases global cytosine methylation 
from approximately 5.3% to 5.75% in a mass spectrometry-based quantification (Dawlaty 
et al, 2013). This finding extends to various tissues with a surprisingly low correlation 
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between the abundance of 5hmC and the extent of methylation gain in TET1/2 knockout. 
For TET3 a role in demethylation has only been reported in preimplantation and brain 
development, although quantitative data are still missing (Gu et al, 2011; Xu et al, 2012). 
In addition to their demethylating activity, TET proteins have also been implicated in 
gene silencing. The first hint came from an early genome-wide map of TET1 and 5hmC 
in murine ES cells (Williams et al, 2011). The authors observed oxidation-independent 
gene upregulation in the absence of TET1 and subsequently linked this effect to a 
physical interaction with the SIN3A co-repressor complex. Another study linked 
hydroxymethylation with gene silencing by reporting a localization of the methylated DNA 
binding protein MBD3 to hydroxymethylated regions (Yildirim et al, 2011). However, this 
is unlikely a consequence of 5hmC mediated recruitment, as MBD3 localization remains 
unaltered in ES cells lacking all three DNMTs (Baubec et al, 2013). 
5-Hydroxymethylcytosine 
5hmC is present in many mammalian cell types with particular abundance in the brain 
tissues (Kriaucionis and Heintz 2009; Tahiliani et al, 2009; Globisch et al, 2010; Dawlaty 
et al, 2013). Mass spectrometry based quantifications of 5hmC revealed that its overall 
amount is rather low and comprises about 1-20% of 5mC, dependent on the analyzed 
tissue or cell types (Globisch et al, 2010; Ito et al, 2011; Dawlaty et al, 2013). For 
instance, embryonic stem cells contain 3% methylated and 0.13% hydroxymethylated 
cytosines which make up approximately 4.25% of methylated cytosines (Ito et al, 2011). 
On the other hand, brain cortex contains 3.1% methylated and 0.67% hydroxymethylated 
cytosines which comprise more than 20% of 5mC. It is possible that increased 
persistence of 5hmC in the brain reflects its accumulation in the absence of replication. 
5hmC has been reported to be enriched in gene bodies and distal regulatory regions, 
however absent from CpG islands, the major sites of TET1 protein binding (Pastor et al, 
2011; Song C.X. et al, 2011; Williams et al, 2011). Its prevalence led to the hypothetic 
function as a signaling module on itself, particularly in neural tissues (Mellen et al, 2012). 
This seems unlikely, as only few 5hmC-specific readers could be identified in recent 
proteomic analysis of hydroxymethylated baits (Iurlaro et al, 2013; Spruijt et al, 2013).  
Further processing of 5hmC involves different mechanisms, often co-occurring with other 
demethylation pathways (Figures 2-7 and 2-8). Presence of 5hmC could facilitate 
passive demethylation by exclusion of DNMT1 from hemi-hydroxymethylated DNA 
(Valinluck and Sowers 2007). This mechanism has been reported to act in the 
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demethylation of paternal pronucleus (Inoue and Zhang 2011). However, UHRF1 binding 
at hemihydroxymethylated DNA has been suggested to be reduced (Hashimoto et al, 
2012) but present (Frauer et al, 2011). Thus, DNMT1 recruitment to hemi-
hydroxymethylated DNA cannot formally be excluded, suggesting possible maintenance 
methylation to occur in the presence of 5hmC. Further supporting this hypothesis, 
hydroxymethylated episomal plasmids become fully methylated upon transfection into 
293T cells (Kubosaki et al, 2012). 
 
 
Figure 2-7 5hmC-induced passive demethylation. 
Hydroxymethylation can facilitate passive demethylation through exclusion of DNMT1-UHRF1 
binding from hemi-hydroxymethylated DNA. Adapted from (Pastor et al, 2013).  
In addition, active demethylation has been proposed to be involved in removal of 5hmC. 
An intriguing hypothesis has been raised by an in vitro study, suggesting that DNMT3A 
and DNMT3B function as dehydroxymethylases (Chen et al, 2012). However, the 
relevance and necessity of such reaction is unclear, considering that DNMT3A/B should 
also be capable of direct conversion of 5mC to C according to the same research group 
(Chen et al, 2013a). 
In an alternative scenario 5hmC is deaminated to 5-hydroxymethyluracil by the 
AID/APOBEC family of deaminases followed by DNA repair mediated excision as 
described above. Initial evidence for such reaction came from a study in which TET1 was 
overexpressed in HEK293 cells together with different enzymes of the AID/APOBEC 
family (Guo et al, 2011a). However, Nabel et al. detected only negligible amounts of 
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deamination products upon overexpression of AID/APOBEC along with TET2 in the 
same cell line (Nabel et al, 2012). Deamination of 5hmC by AID has furthermore been 
challenged by two publications where AID and APOBEC activities on differentially 
modified substrate DNA have been investigated in vitro (Nabel et al, 2012; Rangam et al, 
2012). Both studies report a failure to deaminate hydroxymethylcytosine. Furthermore 
they show that the deaminase activity is anticorrelated to the electron cloud size of the 
cytosine modification. This size selectivity might exclude 5hmC from the catalytic pocket. 
 
 
Figure 2-8 5hmC mediated active demethylation.  
5hmU: 5-hydroxymethyluracil; green: DNMT, pink: TET proteins, orange: DNA repair pathways, 
grey: unidentified enzymatic activity. Adapted from (Pastor et al, 2013). 
Following oxidation of 5mC, TET proteins can sequentially oxidize 5hmC to two 
additional products: 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) (Globisch et 
al, 2010; He et al, 2011; Ito et al, 2011). Enzymatic activity of TET proteins declines for 
later oxidation steps (Ito et al, 2011) which might explain the overall low abundance of 
5fC and 5caC (about 1.5% and 0.2% of 5hmC in ES cells, respectively). This observation 
makes it less likely that oxidation is the major demethylation pathway (Globisch et al, 
2010). Nevertheless, it has been proposed that these products are removed by DNA 
repair machinery with TDG as the main candidate (He et al, 2011; Ito et al, 2011). In 
support of this hypothesis, TDG knockout indeed displays an increase of both 
modifications in embryonic stem cells (Shen et al, 2013; Song et al, 2013). Alternatively, 
5fC and 5caC could be directly removed by a yet unidentified enzyme present in 
embryonic stem cell extracts (Schiesser et al, 2013). 
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2.4.5 Regulatory potential of DNA methylation 
The exact transcriptional role of DNA methylation has been discussed for many years 
(Holliday and Pugh 1975; Riggs 1975). A first experimental evidence for a role in gene 
repression came from methylation comparison within the chicken ß-globin locus between 
an expressing and a non-expressing cell line (McGhee and Ginder 1979). One year later 
Jones and Taylor showed the importance of DNA methylation for cellular differentiation 
by incorporation of the cytosine analogue 5-azacytidine into DNA (Jones and Taylor 
1980). The first direct link between DNA methylation and gene silencing was established 
when retroviral genomes introduced during mouse embryogenesis were de novo 
methylated and silenced (Jahner et al, 1982). However, it is not entirely clear, whether 
methylation always has a regulatory role or whether its presence is a consequence of a 
lack of activation of individual genes.  
The role of DNA methylation in silencing is well established for three phenomena: 
transposon silencing, imprinting and inactivation of genes at the X-chromosome in 
females. DNMT1 knockout mice display increased intracisternal A-type particle (IAP) 
expression and retrotransposition (Walsh et al, 1998; Gaudet et al, 2004). At the same 
time, monoallelic expression of the Igf-2, Igf-2r and H19 genes is misregulated in these 
embryos (Li et al, 1993). Stable silencing of one X-chromosome in female animals was 
demonstrated to rely on DNA methylation in embryonic, but not in extra-embryonic 
tissues using a DNMT1 knockout (Sado et al, 2000). While DNA methylation is recruited 
to most silenced genes on the inactivated X-chromosome this appears after initial 
silencing by histone modifications (Okamoto and Heard 2009). Thus, it seems likely that 
methylation is involved in the maintenance of X-inactivation. 
2.4.5.1 Gene-specific regulation 
Genome-wide DNA methylation in vertebrate genomes theoretically allows for gene-
specific regulation. Consequently, it has been suggested that methylation negatively 
affects transcription by impeding initiation (Klose and Bird 2006). However, microarray 
analysis of an embryonic stem cell line in which all three DNMTs have been deleted 
argues for a relatively small impact of methylation on gene expression, as only about 50 
genes are significantly affected (Sakaue et al, 2010). Furthermore, relatively few 
promoters significantly change their methylation status during development and 
differentiation (Mohn et al, 2008; Borgel et al, 2010; Challen et al, 2012). At least for 
some of them it has been reported that de novo methylation occurs after initial silencing 
by histone modifications (Feldman et al, 2006). Nevertheless, several studies 
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demonstrated that germline-specific genes rely on DNA methylation for silencing in 
thymus, MEFs, primordial germ cells or embryos (Borgel et al, 2010; Velasco et al, 2010; 
Hackett et al, 2012).  
Regions with a high correlation between silencing and DNA methylation have an 
elevated CpG density, suggesting that the density of DNA methylation is more decisive 
for gene repression than the pure presence of the mark (Boyes and Bird 1992; Weber et 
al, 2007). This association has been proposed by an early study in which the effect of 
different fractions of in vitro methylated CpGs within an episomal plasmid on gene 
expression has been analyzed (Hsieh 1994). In this report a methylation of only 7% of 
the CpG dinucleotides decreases transcription of a luciferase reporter gene to 10%. 
Recently, DNA methylation density has been reported to correlate with the enrichment of 
methyl-CpG binding proteins which affect transcription by changing the chromatin 
environment (Nan et al, 1998; Baubec et al, 2013). Nevertheless, a negative correlation 
between activity and DNA methylation can also occur at CpG poor regions, as has been 
demonstrated for distal regulatory regions (Stadler et al, 2011).  
2.4.5.2 Mechanisms of methylation mediated gene repression 
An interesting hypothesis suggests that global DNA methylation generally decreases the 
genome accessibility and thus increases the barrier for active transcription and reduces 
transcriptional noise (Bird 1995). Possible silencing mechanisms involve exclusion of 
activators and attraction of repressors (Klose and Bird 2006). A direct inhibition can 
occur when a transcription factor is sensitive to CpG methylation within its binding site. 
However, only a few TFs have been reported to be directly repelled by DNA methylation 
in their motif including E2F, CREB and YY1 (Iguchi-Ariga and Schaffner 1989; 
Campanero et al, 2000; Kim et al, 2003; Elliott et al, 2010). Other factors, for example 
Sp1, appear insensitive (Harrington et al, 1988; Tate and Bird 1993). CTCF, the 
canonical protein for selective binding of unmethylated DNA regions, can occupy 
methylated CpG poor regions (Bell and Felsenfeld 2000; Stadler et al, 2011).  
Indirect inhibition can be mediated by proteins recognizing methylated CpG 
dinucleotides. Two families have been described. Methyl-CpG-binding domain (MBD) 
proteins directly recognize methylated CpGs and occupy DNA in a methyl-CpG density 
dependent fashion (Tate and Bird 1993; Baubec et al, 2013). The second group contains 
proteins which recognize methylated CpGs in a sequence-specific context by their zinc-
fingers (including KAISO, ZBTB4, ZBTB38 and ZFP57, (Filion et al, 2006)). Both could 
sterically counteract activator binding or recruit repressive histone modifiers. In their 
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pioneering work the research groups of Bird and Wolffe reported physical interaction 
between MeCP2 and Sin3A which in turn forms a complex with HDAC1/2. Upon binding 
to methylated regions MeCP2 thus triggers their deacetylation and ultimately silencing. 
Importantly, silencing depends on the deacetylase activity, as its inhibition by 
Trichostatin A derepresses reporter genes (Jones et al, 1998; Nan et al, 1998). In this 
case, while facilitated by DNA methylation, silencing is mediated through other factors. 
2.4.5.3 Protection from DNA methylation 
It is possible that gene activity and active chromatin counteract DNA methylation. For 
example, in vitro assays demonstrated that trimethylation of lysine 4 at histone 3 
sterically excludes DNMT3L from CpG islands and thus protects them from recruitment 
of DNMT3A/B (Ooi et al, 2007). CpG islands can furthermore attract CXXC domain 
proteins which might contribute to their active chromatin state (Long et al, 2013b). Such 
a protein, TET1, which is strongly enriched at CpG islands (2.4.4.4) could actively keep 
them unmethylated and accessible for other factors (Pastor et al, 2013). 
In addition, binding of certain transcription factors might protect from DNA methylation 
(Brandeis et al, 1994; Macleod et al, 1994; Lienert et al, 2011). Importantly, TF 
occupancy is not solely of a protective nature, but can induce demethylation in vivo via a 
yet unidentified mechanism (Thomassin et al, 2001; Xu et al, 2009; Stadler et al, 2011). 
Recruitment of the E. coli Lac repressor LacI to in vitro premethylated Lac operator 
sequence induces demethylation in a human cell line. Interestingly, titration of LacI by 
supplementation with IPTG suggests that the extent of demethylation directly correlates 
with occupancy of the target site but not with transcriptional activity (Lin et al, 2000). 
Similar conclusions were obtained from a study in fertilized Xenopus eggs for different 
transactivator domains (Matsuo et al, 1998). This study carries the functional analysis 
further and shows that demethylation by binding of TFs requires ongoing replication, 
suggesting a passive demethylation mechanism.  
2.4.5.4 Role of 5mC derivatives 
In theory, oxidation products of 5mC could also participate in gene regulation, although 
here the described relationship is even more complicated (Kriaucionis and Heintz 2009; 
Tahiliani et al, 2009; He et al, 2011; Ito et al, 2011). As intermediates of active 
demethylation and if DNA methylation is repressive, one would expect them to have an 
activating role. However, high 5-hydroxymethylcytosine enrichments at the TSS 
negatively correlate with gene expression (Pastor et al, 2011). Considering that most 
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promoters are CpG islands and bisulfite sequencing does not distinguish between 5mC 
and 5hmC (Huang et al, 2010), this anticorrelation is hardly surprising. Conversely, high 
gene-body enrichments have been associated with increased gene expression in brain 
tissue and in embryonic stem cells (Song C.X. et al, 2011; Wu et al, 2011; Mellen et al, 
2012; Colquitt et al, 2013). This pattern resembles the distribution of 5mC so much that 
the presence of 5hmC within these sites is likely to be a consequence of substrate 
enrichment. Gel shift assays furthermore suggest that MeCP2 is a reader of 5hmC 
(Mellen et al, 2012), a finding confirmed by a mass spectrometry approach (Spruijt et al, 
2013). However, these results are challenged by an older study in which the binding 
affinity of MeCP2 was measured in vitro for oxidative damaged 5mC DNA (Valinluck et 
al, 2004).  
On the other hand, further oxidation of 5hmC appears to be detrimental for transcription, 
as in vitro elongation efficiency of the RNA polymerase II decreases at 5fC and 5caC 
containing targets (Kellinger et al, 2012).  
Despite these correlative findings, changes in 5hmC levels could not be linked to 
concomitant changes in gene expression in a knockdown of TET1 (Williams et al, 2011). 
In summary, these findings do not allow to clearly discriminate the transcriptional effects 
of 5mC and its derivatives.  
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2.5 Scope of this thesis 
Cell type specific gene expression programs require regulatory mechanisms which are 
capable to correctly interpret genetic information for each cell. Gene regulation ultimately 
relies on the interaction of transcription factors with their cognate sequences. Positive or 
negative modulation of such interactions is thus the function of any gene regulatory 
mechanism. In eukaryotes, this is achieved through the concerted action of nucleosomes 
and chromatin modifications.  
When I started my PhD thesis, growing evidence suggested a role of DNA sequences in 
determination of epigenetic states, such as DNA methylation and trimethylation of lysine 
27 of histone H3 (Lienert et al, 2011; Stadler et al, 2011; Arnold et al, 2013). In these 
studies establishment of chromatin state critically depended on the presence of 
transcription factors.  
While DNA methylation has long been considered a stably repressive modification which 
is reprogrammed in germ cells and early embryogenesis (Wu and Zhang 2010), it 
became increasingly clear that this mark is reversible upon cellular differentiation (Mohn 
et al, 2008; Klug et al, 2010). Importantly, this process appears to depend on binding of 
transcription factors (Stadler et al, 2011). Advances in sequencing technologies allowed 
for a direct genome-wide measurement of DNA methylation. This revealed that its 
dynamic changes are especially pronounced at low methylated regions which are on 
average 30% methylated and often coincide with distal regulatory elements (Stadler et 
al, 2011). How exactly transcription factors induce hypomethylation and how stable is the 
achieved hypomethylated state remained undetermined. 
We used two approaches to further investigate the relationship between transcription 
factors and DNA methylation at low methylated regions. First, we performed genome-
wide chromatin immunoprecipitation of CTCF followed by bisulfite conversion and 
sequencing of the enriched DNA (Brinkman et al, 2012; Statham et al, 2012) to assess 
whether methylation is directly coupled to TF occupancy at the level of single molecules. 
By the time of performed experiments it has been suggested that DNA demethylation is 
achieved through oxidation of 5-methylcytosines to 5-hydroxymethylcytosine by the TET 
family of proteins (Kriaucionis and Heintz 2009; Tahiliani et al, 2009). Therefore, in a 
second approach we tested this hypothesis by using hydroxymethylated DNA 
immunoprecipitation followed by sequencing (Weber et al, 2005; Wu et al, 2011) during 
neuronal differentiation of embryonic stem cells. To further characterize the relationship 
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between transcription factor binding and DNA hydroxymethylation, we used a cell line 
bearing a genetic deletion of the factor REST. We then assessed the stability of DNA 
methylation in embryonic stem cells with a stable knockout or conditional inactivation of 
the two de novo DNA methyltransferases DNMT3A and DNMT3B. In order to quantify a 
potential turnover we measured methylation throughout a time-course of DNMT3A/B 
deletion by sequencing bisulfite PCR amplicons derived from different genomic regions.  
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3 Results 
3.1 Transcription factor occupancy can mediate active 
turnover of DNA methylation at distal regulatory regions 
Feldmann A*, Ivanek R*, Murr R*, Gaidatzis D, Burger L and Schübeler D 
3.1.1 Summary 
Cellular differentiation and development are largely regulated by distal regulatory 
elements, including enhancers and insulators. Binding of transcription factors to these 
elements is critical for their activity and coincides with locally reduced methylation 
(Stadler et al, 2011). Importantly, transcription factor binding is necessary and sufficient 
for formation of such low methylated regions (LMRs), even if they were previously 
methylated. How exactly these hypomethylated states are created and how transcription 
factor occupancy translates into DNA methylation is poorly understood. 
Here we chose the DNA binding factor CTCF which has been previously shown to create 
LMRs as test case to investigate the relationship between DNA methylation and 
transcription factor binding. Using chromatin immunoprecipitation followed by bisulfite 
sequencing we show that in contrast to imprinted loci where only the unmethylated allele 
is occupied, CTCF can bind any methylation state at LMRs. We find an inverse 
relationship between occupancy and DNA methylation. Cytosines within sites of high 
CTCF enrichments have a high probability to be unmethylated as opposed to low 
occupancy sites, for which DNA methylation is heterogeneous. Our data suggest that 
CTCF binding is not statically linked to an unmethylated state but instead argue for a 
dynamic model of interaction in which methylated or unmethylated cytosines can be 
bound. In line with this model, we observe high enrichments of 5-hydroxymethylcytosine 
at cell type specific LMRs in embryonic stem cells and upon their neuronal differentiation, 
providing a mechanism for transcription factor dependent local demethylation. Moreover, 
cell type specific LMRs are enriched among sites of dynamic hydroxymethylation. As 
deletion of CTCF is lethal for embryonic stem cells, the link between transcription factor 
occupancy and hydroxymethylation was tested by profiling hydroxymethylation in a cell 
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line in which REST - another transcription factor implicated in LMR formation - was 
genetically deleted. This revealed an increase in DNA methylation and concomitant 
decrease of hydroxymethylation at REST bound LMRs. 
Our results argue that transcription factors have the potential to induce TET protein 
dependent turnover of DNA methylation for maintenance and reprogramming of distal 
regulatory regions. 
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Abstract
Distal regulatory elements, including enhancers, play a critical role in regulating gene activity. Transcription factor binding
to these elements correlates with Low Methylated Regions (LMRs) in a process that is poorly understood. Here we ask
whether and how actual occupancy of DNA-binding factors is linked to DNA methylation at the level of individual
molecules. Using CTCF as an example, we observe that frequency of binding correlates with the likelihood of a
demethylated state and sites of low occupancy display heterogeneous DNA methylation within the CTCF motif. In line with
a dynamic model of binding and DNA methylation turnover, we find that 5-hydroxymethylcytosine (5hmC), formed as an
intermediate state of active demethylation, is enriched at LMRs in stem and somatic cells. Moreover, a significant fraction of
changes in 5hmC during differentiation occurs at these regions, suggesting that transcription factor activity could be a key
driver for active demethylation. Since deletion of CTCF is lethal for embryonic stem cells, we used genetic deletion of REST
as another DNA-binding factor implicated in LMR formation to test this hypothesis. The absence of REST leads to a decrease
of hydroxymethylation and a concomitant increase of DNA methylation at its binding sites. These data support a model
where DNA-binding factors can mediate turnover of DNA methylation as an integral part of maintenance and
reprogramming of regulatory regions.
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Introduction
Correct spatial and temporal regulation of genes depends on
distal regulatory elements. Reprogramming the activity of these
elements is thus central for successful cellular specialization [1,2].
Active distal regulatory elements are characterized by an open
chromatin structure, corresponding to DNaseI hypersensitive sites,
specific histone variants and histone modifications [3,4]. These
modifications are thought to regulate the accessibility of the
regulatory sequence and thus facilitate transcription factor (TF)
binding [5].
Distal regulatory regions that reside outside of CpG islands are
further unique, as they show reduced levels of DNA methylation
when active [6–8]. Importantly, this feature is consistent between
cell types so that it can be implemented to identify cell-type specific
active regulatory elements as Low Methylated Regions (LMR)
[6,7,9–11]. Although reduced, DNA methylation at LMRs is
maintained at a residual level. This reflects heterogeneity within
the population of sequenced DNA molecules, given that DNA
methylation is binary for any particular cytosine. Functional
experiments suggested that reduced methylation at LMRs
critically depends on binding of transcription factors [7], but their
role in creating methylation heterogeneity and whether this occurs
via a passive and/or an active demethylation remains to be
identified.
Several lines of evidence further link DNA demethylation to
enhancer activity. Demethylation occurs at glucocorticoid receptor
binding sites [8] and 5-hydroxymethylcytosine (5hmC), an
intermediate of active demethylation via oxidation of 5-methyl-
cytosines (5mC) by TET proteins [12–16], is present at active
enhancers in embryonic stem (ES) cells as well as during neuronal
and adipocyte differentiation [7,17–21]. Importantly, 5hmC can
readily be detected in various cell types and thus utilized to locate
regions of active DNA demethylation [22,23].
Here we addressed, whether heterogeneous methylation at
LMRs reflects differential occupancy by transcription factors at
individual molecules, using the DNA binding factor CTCF as an
example. We show that CTCF-bound molecules display similar
methylation levels as those observed in the entire cell population at
CTCF binding sites. Moreover, for cytosines located within the
CTCF motif, we find that binding affinity correlates with the
likelihood of being unmethylated, so that CTCF is able to bind
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any methylation state within low occupancy sites. On the other
hand, we find that high levels of hydroxymethylation coincide with
the observed low methylation at LMRs, in a process that accounts
for up to 20% of the genome-wide dynamics of 5hmC during
neuronal differentiation of ES cells. Moreover, the presence of
hydroxymethylation depends, at least partially, on TF binding,
since genetic deletion of RE1-silencing transcription factor (REST)
results in reduced hydroxymethylation at bound LMRs. Our
results support a model where TF binding can occur at methylated
regions and induce methylation turnover within active regulatory
elements.
Results
Relation between CTCF occupancy and methylation
states at CpG poor regions
Apart from CpG islands, mammalian genomes are mostly
methylated. Notable exceptions are LMRs, CpG poor regions that
display an average methylation level of 30% as measured by
bisulfite sequencing (BisSeq). This reduced methylation marks
active distal regulatory regions as it coincides with DNaseI
hypersensitivity and enhancer-characteristic histone modifications
[7]. We previously showed that, in the case of REST and CTCF,
binding of trans-acting factors to DNA is required for LMR
formation, yet it remains unclear whether and how this binding is
related to the observed variation of DNA methylation between
sequenced molecules [7]. Assuming a static model, unmethylated
DNA would be limited to those molecules that are occupied by a
TF, which in turn predicts that methylated molecules are not
occupied, as has been established for imprinted CpG islands
(Figure 1A, left) [24,25]. Alternatively, TFs could occupy all
variations of methylation levels within LMRs (Figure 1A, right).
To test the first scenario, we performed Chromatin-IP (ChIP) in
ES cells against the DNA binding factor CTCF and conducted
bisulfite sequencing of the immunoprecipitated CTCF-bound
DNA (ChIP-BisSeq) (Figure 1B) [26,27]. Importantly, the CTCF-
ChIP enrichments recovered in our ChIP-BisSeq samples highly
correlate with published ChIP enrichments [7] (r = 0.91 and 0.90
for replicate1 and replicate2, respectively) as well as between the
replicate experiments (r = 0.91) (Figure S1A). Equally important,
methylation for single cytosines correlates between the two
replicates (r = 0.8, Figure S1B).
Only those CpGs, which show intermediate levels of methyl-
ation in BisSeq, can be informative to address our hypothesis.
Therefore we first focused on CTCF sites located within LMRs. In
this context it should be mentioned that the mean methylation of
30% observed at an LMR represents an average of individual
cytosines within this LMR that can vary widely in their
methylation percentage ([7] and data not shown). To ask if this
heterogeneity is reduced at the occupied molecules, we compared
methylation levels between the CTCF-bound fraction and the
total population of cells. We first analyzed CpGs residing in sites of
known allelic variation in CTCF binding, corresponding to
DMRs, where we indeed only recover the unmethylated alleles
in the ChIP-BisSeq assay (Figure 1B–C). This agrees with a recent
report and confirms that our ChIP-BisSeq provides correct
methylation status of bound molecules [25,26].
Next we asked if methylation patterns at CTCF-bound LMRs
differ between exclusively bound molecules and the total
population of DNA molecules. We analyzed average methylation
levels for 200 bp regions centered at a CTCF motif only for those
motifs which (1) overlap with LMRs, (2) are bound by CTCF as
determined by ChIP enrichments and (3) for which all considered
cytosines are covered at least 10 times in both ChIP-BisSeq and
whole-genome (WG-) BisSeq. It is important to mention here, that
while our ChIP does not allow for calling high resolution peaks
such as those determined by other methods like ChIP-exo [28],
our analysis pipeline is able to correctly identify high confidence
bound sites as it requires CTCF motif in the center of the analyzed
region in addition to high ChIP enrichment. This revealed a
positive correlation with an equal spread of the data over the
entire range (r = 0.67), arguing that LMRs do not display global
differences in methylation levels at CTCF binding sites between
the fraction of molecules bound by CTCF and those representing
the total population of molecules in cells (Figure 1B). This finding
is illustrated at individual loci (Figure 1C) and extends to CTCF
binding sites outside of LMRs (Figure S1C).
We notice however that while entire LMRs do not display
reduced methylation in the actually bound fraction of molecules,
some individual cytosines in the vicinity of the CTCF motif do so
(for example LMR1 in Figure 1C). To determine whether reduced
methylation in CpGs close to the CTCF motif is a global
phenomenon, we correlated changes in methylation between
ChIP-BisSeq and WG-BisSeq with the distance to the nearest
CTCF motif for individual cytosines with a minimal coverage of
10 fold in WG-BisSeq and ChIP-BisSeq in CTCF-bound Low
Methylated Regions. This analysis revealed no correlation,
suggesting that CTCF binding does not affect the methylation of
proximal cytosines more than it does for the distal ones (Figure
S1D). Therefore, the heterogeneity of occupancy by CTCF cannot
explain the observed heterogeneity of methylation within LMRs,
even though these can form upon CTCF binding and thus, at least
in part, are CTCF dependent [7].
To further test the relationship between occupancy and
methylation state, we next focused our analysis exclusively on
CpGs that reside within a CTCF motif. We and others have
Author Summary
Cell identity is determined by differential gene expression,
which in turn is controlled by the combined activity of
proximal and distal regulatory elements such as enhancers.
DNA within active enhancer elements is marked by a
hypomethylated state as a result of transcription factor
(TF) binding. Here, using CTCF as an example for a DNA-
binding factor, we explore the relationship between
binding and DNA methylation at the level of single
molecules by enriching for CTCF occupied DNA. To our
surprise, methylation at molecules which are bound by
CTCF does not differ from the average methylation levels
at the binding sites defined by whole-genome bisulfite
sequencing. We find that binding strength inversely
correlates with DNA methylation within the CTCF motif
with heterogenic methylation levels at low occupancy
sites, suggesting that CTCF can bind to molecules with
different methylation states. Moreover, we observed
enrichment of 5-hydroxymethylcytosines at constitutive
and cell-type specific TF binding sites indicative of an
active demethylation process. To test the requirement of
TF binding for the observed hydroxymethylation, and as
CTCF deletion is incompatible with the survival of
embryonic stem cells, we made use of cells in which REST
– a factor which was previously shown to be involved in
LMR formation - was genetically deleted. This deletion
leads to loss of hydroxymethylation at its binding sites,
suggesting that binding is necessary for turnover. Our data
support a model in which TF occupancy mediates a
continuous turnover of DNA methylation during mainte-
nance and formation of active regulatory regions.
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previously shown that methylation around occupied CTCF sites is
the lowest at the actual binding motif and increases outwards
[7,21]. Notably, 57% of all occupied sites by CTCF do not contain
a CpG within the binding motif, yet display the same methylation
pattern around the site (Figure 1B, Figure S1 and data not shown).
Out of all predicted CTCF binding sites, 24.5% contain at least
one CpG (Figure 2A–B). For all these sites, we related the strength
of binding by CTCF as measured by ChIP enrichment to the
methylation state of single CpGs within the motif. This reveals that
strongly and weakly bound sites indeed differ in their methylation
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Figure 1. Relation between CTCF occupancy and methylation states in CpG poor regions. (A) LMRs are bound by transcription factors (TF)
and have intermediate average methylation levels. There are two possible scenarios how TF binding and DNA methylation at CpG poor regions could
be linked. In a static situation (left), TF binding would be linked to the unmethylated state of the bound molecule, whereas unbound molecules are
fully methylated as previously shown for imprinted CpG islands. In an unlinked model (right), TF binding is independent of the DNA methylation
state, therefore bound molecules display the same variation of methylation levels as the entire population. (B) To distinguish these scenarios we
enrich for bound molecules by ChIP and determine their methylation by bisulfite sequencing (ChIP-BisSeq). This results in a high correlation of
methylation levels between ChIP-BisSeq (y-axis) and whole genome bisulfite sequencing (WG-BisSeq, x-axis). Each point represents average
methylation over a 200 bp region. Shown are only regions centered at a bound CTCF motif which overlaps with an LMR and for which all considered
cytosines have a minimal coverage of 106 in both, WG-BisSeq and ChIP-BisSeq. Red points represent average for 200 bp windows centered on CTCF
motifs located within DMRs. Boxplots show mean deviation of methylation levels in ChIP-BisSeq from those in WG-BisSeq at LMRs and DMRs in
percent methylation. (C) Examples of single cytosine methylation levels in WG-BisSeq (top bars) and ChIP-BisSeq (bottom bars). For LMRs a whole
segment is shown. Each bar represents a cytosine. Methylation is shown in a color code (red: high, yellow: low). Position of CTCF motifs is indicated by
black triangles. Only cytosines with at least 106 coverage in both, WG-BisSeq and ChIP-BisSeq, are shown.
doi:10.1371/journal.pgen.1003994.g001
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(Figure 2C). CpGs within highly occupied sites tend to be
completely unmethylated, while methylation shifts towards inter-
mediate levels with decreasing binding affinity. This links
frequency of occupancy to methylation levels within the CTCF
motif.
Again we can ask if heterogeneous methylation at weakly bound
sites reflects actual occupancy at the level of individual molecules
by analyzing their methylation in the bound fraction that was
enriched by CTCF-ChIP. Also at these selected CpGs the
methylation of exclusively occupied molecules is similar to the
methylation of the total population (Figure 2D–E). Importantly,
this relationship between the methylation state and CTCF binding
is not dependent on the position of the analyzed CpG, as
illustrated by the analysis of CpGs positioned exclusively at
position 5–6 of the consensus motif (Figure S2).
Together, our data suggest that actual factor occupancy at the
level of single molecules does not explain the observed DNA
methylation heterogeneity adjacent to CTCF sites within LMRs or
at the motif itself throughout the genome. This argues against a
scenario of static methylation at CpG poor regions (Figure 1A,
left), where DNA in a fraction of cells is bound by a TF and
unmethylated, while other molecules are never occupied and
remain methylated. Alternative scenarios could involve binding of
a TF independently of methylation states, which in turn could
trigger active demethylation (Figure 1A, right).
Hydroxymethylation marks LMRs in a cell-type specific
and transcription factor binding dependent fashion
To ask if LMRs are indeed sites of active DNA methylation
turnover, we determined the presence of 5hmC, the intermediate
of TET mediated oxidation. Notably, bisulfite does not convert
5hmC and thus a fraction of the residual unconverted cytosines at
LMRs could represent hydroxymethylcytosines [29,30]. We
enriched for this modification by performing hydroxymethylcyto-
sine DNA-immunoprecipitation (hMeDIP) followed by high
throughput sequencing (hMeDIP-seq) in stem cells [31,32].
Analysis of the 5hmC profiles revealed its enrichment at LMRs
of ES cells in line with other reports that suggested its presence at
stem cell enhancers (Figure 3A) [19,21]. Analysis of an existing
map of genomic binding sites further reveals that also TET1, an
enzyme that mediates oxidation to 5hmC, is strongly enriched at
LMRs in ES cells (Figure 3A) [33].
To address, whether the presence of 5hmC at LMRs is limited
to stem cells or conserved in committed cells, we performed
hMeDIP-Seq in neuronal progenitors (NP), derived through
controlled differentiation of ES cells [34]. We previously showed
C D E
A B
Figure 2. Relationship between binding strength and DNA methylation within the CTCF motif. (A) CTCF consensus motif used in this
study [7]. (B) Percent of predicted CTCF sites containing a CpG within the motif. Exclusively these CpGs are shown in the plots (C–E). (C–E) Each point
represents one individual CpG within a CTCF motif. (C) Correlation of methylation and CTCF enrichment identifies three classes of CTCF sites:
unbound (light-blue), strongly bound and unmethylated (dark-blue), weakly bound with intermediate levels of methylation (blue). The red line
represents a running mean measurement of methylation. (D) Same as C, but only showing cytosines covered in both WG-BisSeq and CTCF ChIP-
BisSeq. (E) Same as D but only showing methylation levels derived from CTCF ChIP-BisSeq. In each case bound molecules show the same pattern as
the entire population. Only cytosines residing within the CTCF binding motif and with a minimal coverage of 106 are shown. In order to prevent
over-plotting the points were jittered with a standard deviation of 2%.
doi:10.1371/journal.pgen.1003994.g002
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in the same differentiation system that a large set of LMRs is cell-
type specific, reflecting the extensive reprogramming of distal
regulatory regions during somatic differentiation [7]. The resulting
genomic 5hmC profiles reveal its enrichment at LMRs also in NP
(Figure 3B–C). LMRs that are constitutive in both cell types show
constitutive hydroxymethylation, suggesting that oxidation of 5-
methylcytosine at LMRs also occurs in somatic cells (Figure 3B–
C). ES-specific LMRs gain methylation and concomitantly lose
hydroxymethylation in NP, suggesting that the state of reduced
methylation and the presence of 5hmC coincide at active
regulatory elements (Figure 3B–C, Figure S2). Similarly, NP-
specific LMRs show a decrease in methylation and gain of
hydroxymethylation along differentiation (Figure 3B–C, Figure
S3). Notably, these NP-specific LMRs are enriched for neuron-
specific TF binding sites, further confirming the link between TF
binding at CpG poor regions and the presence of 5hmC [7]. The
observed reciprocal behavior between loss of 5mC and gain of
5hmC is a general feature, as a genome-wide anti-correlation
A
B
C
Figure 3. 5hmC marks LMRs in a cell-type specific fashion. (A) Average profiles for methylation (WG-BisSeq), 5hmC (hMeDIP-seq) and TET1
occupancy at Fully Methylated, Unmethylated and Low Methylated Regions (FMRs, UMRs and LMRs, respectively) in ES cells. (B) DNA methylation
(upper tracks) and enrichment of 5hmC (lower tracks) in ES cells and NP of representative ES-specific, constitutive and NP-specific LMRs. (C) Average
profiles representing methylation (WG-BisSeq), hMeDIP-seq and H3K4me1 ChIP-Seq in ES cells and NP 63 kb around the segment middle.
doi:10.1371/journal.pgen.1003994.g003
TF Mediated Turnover of DNA Methylation
PLOS Genetics | www.plosgenetics.org 5 December 2013 | Volume 9 | Issue 12 | e1003994
between changes in hMeDIP-Seq and WG-BisSeq (r =20.58) as
well as between changes in hMeDIP-Seq and MeDIP-Seq
(r =20.30, Figure S3) exists at LMRs.
To determine, if the observed turnover is selective for LMRs, we
quantified 5hmC enrichments by hMeDIP-Seq throughout the
genome and calculated the differences between ES cells and NP in
order to identify genomic regions that show changes in the level of
5hmC. This revealed that cell-type specific enrichments for 5hmC
show a large overlap with cell-type specific LMRs. This selectivity
is further evident when calculating the occurrence in relation to
genomic coverage (Figure 4). In this analysis, ES-specific LMRs
are eightfold overrepresented in genomic regions that show
enrichment for 5hmC in ES cells and the selectivity is even
higher in NP, where NP-specific LMRs are more than 40-fold
overrepresented.
This strong correlation suggests that transcription factors are
required to induce hydroxymethylation. Indeed, 5hmC is more
enriched at bound than at unbound CTCF motifs (Figure S4). To
directly test whether increased 5hmC enrichment is a consequence
of TF binding, we wanted to use a loss of function approach.
Absence of CTCF, notably in ES cells, is cellular lethal [35–38],
which precludes monitoring changes in methylation in cells that
lack CTCF but otherwise are phenotypically normal. Effective
depletion of CTCF would however be required in order to directly
test its requirement in trans, since conserved binding sites remain
occupied upon knockdown of CTCF [39]. As CTCF deletion is
incompatible with survival of ES cells, we made use of a
phenotypically normal ES cell line in which the Rest gene, coding
for a different TF that is enriched within LMRs, had been
genetically deleted. More specifically, we determined the level of
hydroxymethylation at REST-bound LMRs. These regions
become fully methylated in the absence of REST as measured
by bisulfite sequencing, which is not discriminating between 5mC
and 5hmC (Figure 5A–B). When measuring hydroxymethylation
specifically by hMeDIP (see Table S1 for primers) we find that
5hmC levels are significantly reduced at these binding sites in
REST knockout ES cells (Figure 5C). This indicates that factor
activity in trans is required for increased hydroxymethylation at
LMRs within a given cell type.
These observations are compatible with a scenario in which
reduced DNA methylation at regulatory regions entails the
presence of active DNA methylation turnover in both stem and
differentiated cells.
Discussion
Using CTCF as example, this study provides further evidence
that maintenance and reprogramming of correct DNA methyla-
tion levels at distal regulatory regions can entail active turnover as
a function of transcription factor binding. We show that the loss of
methylation at these regions during cellular differentiation involves
a reciprocal gain of 5hmC and vice versa. This process occurs
preferentially at LMRs and we demonstrate that it accounts for up
to 20% of all observed changes in 5hmC during differentiation.
These findings are compatible with previous reports of dynamic
hydroxymethylation [18,40]. Importantly, this association is not
limited to stem cells, even though these have been suggested to
display higher global levels of 5hmC than differentiated cells [16].
We also show that this phenomenon can go beyond correlation,
since genetic deletion of the TF REST results in reduced
hydroxymethylation at its binding sites already in stem cells.
Our results obtained from CTCF and REST mechanistically link
binding of TF at regulatory regions with active demethylation.
However, in light of the estimated 1400 different TFs encoded in
mammalian genomes, it would be premature to generalize these
findings.
The fact that CTCF can occupy different methylation states in
CpG poor regions together with the presence of both 5hmC and
TET1 at these sites is compatible with a scenario, where TF
binding triggers an active demethylation process. In case of CTCF
it is evident that the binding strength determined by ChIP relates
directly to the level of demethylation within the binding motif. The
frequency of binding correlates with the likelihood of a demeth-
ylated state for a cytosine within the binding site. Assuming that
this relation extends to factors other than CTCF adds yet another
dimension to whole-genome basepair methylomes by providing
not only information about the activity of regulatory regions, but
also about the strength of binding of trans-acting factors. It is
important to note however that both CTCF and REST are rather
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Figure 4. 5hmC dynamics during differentiation occurs preferentially at LMRs. (A–B) Shown is the relative frequency of changes in 5hmC at
LMRs and UMRs normalized for genome coverage at the ES (A) and NP state (B). The y-axis shows observed linear fold enrichment relative to
expected enrichments (see Materials and Methods). Note that 5hmC is changing preferentially at cell-type specific LMRs.
doi:10.1371/journal.pgen.1003994.g004
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special in regards to the large size of their sequence motifs (20 and
21 bp, respectively), which further limits the ability to generalize
our observations. Clearly, a more comprehensive approach is
needed to address the effect of additional DNA-binding factors on
DNA methylation.
While the actual mode of demethylation remains to be
determined, it seems possible that DNA binding factors recruit
TET proteins, which in turn mediate oxidation to 5hmC [41].
However, in light of the generality of the link between LMR
formation and 5hmC, this would require a large number of
TFs to share such recruitment ability. Alternatively, recruit-
ment might be mediated by general cofactors that are
frequently observed at distal regulatory regions such as p300
or by pioneer factors [3,42]. A further scenario could be that
a specific nucleosome or DNA organization results from
binding of a TF, which in turn triggers TET recruitment
[43].
At this point we can only speculate if 5hmC presence at
regulatory regions solely reflects active turnover [21,44–48] and
how much an active process contributes to the low levels of
methylation observed. Moreover, it remains to be shown if
presence of hydroxymethylation is actually involved in enhancer
regulation. This would require specific readers of this DNA
modification. Indeed, several proteins have been suggested to bind
5hmC, including the MBD domain proteins MeCP2 [49] and
MBD3 [50]. Our recent functional mapping, however, suggested
that genomic binding sites of MBD3 are independent of the
presence of hydroxymethylation [51] in agreement with in vitro
binding [52], making this scenario less likely. In addition, other
putative readers of 5hmC were suggested in a proteomics screen,
yet only few appear to be selective for 5hmC in vitro [52].
Conversely, two recent studies report the accumulation of TET-
mediated 5hmC oxidation products 5-formylcytosine and 5-
carboxylcytosine at proximal and distal regulatory elements in
the absence of TDG [46,47], arguing for the appearance of an
active turnover at LMRs. It remains to be determined, whether
DNA binding factors, such as CTCF and REST used here, are
able to bind to hydroxymethylated regions. While strong CTCF
binding sites are devoid of methylation and hydroxymethylation, it
is possible that CTCF is able to bind to 5mC as well as to 5hmC at
low occupancy sites.
Our findings argue that LMRs do not result solely from a
passive loss of methylation during replication, which is in line with
the observation that LMRs can be detected in methylomes from
non-dividing cells [9] and with recently reported presence of 5-
formylcytosine and 5-carboxylcytosine at these elements [46,47].
At this point we lack experimental evidence for the relevance of
reduced methylation for the function of distal regulatory regions. It
is conceivable, but remains to be shown, that reduced methylation
induced by pioneering TFs would enhance binding of other TFs,
which are sensitive to DNA methylation even in CpG poor regions
[53,54]. Alternatively, but not mutually exclusive, reduced
methylation could mediate a chromatin state that functions as a
general attractor for DNA binding factors and thus would stabilize
the on-state [55].
Materials and Methods
ES cell culture and differentiation
159-2 ES cells were cultured and differentiated as previously
described [7,34].
CTCF ChIP-bisulfite sequencing
Chromatin immunoprecipitation (ChIP) assay for CTCF was
performed according to the Upstate protocol using the antibody
anti-CTCF (SantaCruz #15914). 100 ng of immunoprecipitated
DNA were used for subsequent library preparation. DNA
fragments were end repaired by incubation at 20uC for 30 minutes
with 400 mM dNTP, 3 units of T4 DNA polymerase (NEB
#M0203S), 5 units of DNA Polymerase I Lg. Frag. (Klenow)
(NEB #M0210S), 10 units of T4 PNK (NEB #M0201S), 16T4
DNA ligase buffer containing 10 mM ATP (NEB), followed by
column purification using QIAquick PCR Purification Kit
(QIAGEN #28106). 39 ends of DNA fragments were adenylated
A
B
C
Figure 5. 5hmC enrichment at REST-bound LMRs is partially
dependent on the presence of REST. (A) Relative methylation
changes between REST wildtype and REST knockout ES cells are
correlated to REST ChIP enrichment. Methylation was determined
200 bp around the REST motif at all REST sites overlapping with LMRs.
The point density is colour-coded (red: high, blue: low point density).
Methylation determined by BisSeq (B) and hMeDIP qPCR enrichments
(C) at REST motif containing LMRs bound and not bound by REST in
wildtype (wt, dark blue) and REST knockout (ko, blue) ES cells. Error bars
in (C) represent standard deviation in three replicate experiments
normalized to a positive control.
doi:10.1371/journal.pgen.1003994.g005
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by incubation at 37uC for 30 minutes with 200 mM dATP,
16NEB Buffer 2, 5 units Klenow Fragment (39R59 exo–) (NEB #
M0212L), followed by column purification using MinElute PCR
Purification Kit (QIAGEN # 28006). Adapter for single end
sequencing were reproduced based on Illumina adapter sequenc-
es. Annealed adapters were ligated to the DNA fragments by
incubation at room temperature for 15 min in the following mix:
400 nM of annealed adapters, 16NEB Quick ligase buffer, 2.000
units of T4 Quick ligase (NEB #M2200S), followed by column
purification using MinElute PCR Purification Kit. 200 ng of
Drosophila DNA (Kc cells) were then added as a carrier.
Adapter-ligated DNA of 150–400 bp was selected from 2%
agarose gel electrophoresis and purified using MinElute Gel
Extraction Kit (QIAGEN #28606). BSA (final concentration
0.5 mg/ml) was added to gel-purified DNA and the mix was then
treated with sodium bisulfite using the Imprint DNA Modifica-
tion Kit (Sigma-Aldrich) as per manufacturer’s instructions. DNA
was enriched using 18 cycles of PCR with the following reaction
composition: 2.5 U of uracil-insensitive PfuTurboCx Hotstart DNA
polymerase (Stratagene), 5 ml 106 PfuTurbo reaction buffer,
25 mM dNTPs, 0.5 mM of Single End Illumina PCR primers
(1.1 and 2.1). The thermocycling parameters were: 95uC 2 min,
98uC 30 sec, then 18 cycles of 98uC 15 sec, 65uC 30 sec and
72uC 3 min, ending with one 72uC 5 min step, followed by
column purification using the MinElute PCR Purification Kit.
DNA was then run on 2% agarose gel to separate the library
from adapter dimers and purified using the MinElute Gel
Extraction Kit. Quality of the libraries and template size
distribution were checked on an Agilent 2100 Bioanalyzer
(Agilent Technologies).
RESTko bisulfite sequencing
Library for the shotgun whole-genome BisSeq for RESTko cells
was prepared as previously described [7] and sequenced using one
lane of Illumina HiSeq 2000.
hMeDIP and MeDIP sequencing library preparation
Genomic DNA was fragmented to 200–1000 bp fragments
with a Bioruptor (Diagenode, Sparta, NJ). The protocol for the
library preparation was adapted from Illumina Genomic DNA
Sample Preparation Guide. Briefly, 7 to 10 mg of fragmented
DNA were end repaired and their 39 ends adenylated. Genomic
single end or paired end adapters were annealed. (h)MeDIP was
performed as previously described [56] using 4 ug of adapter-
ligated DNA and 4 ml of a 1:10 dilution of rabbit polyclonal anti-
hmC antibody (Active Motif #39770) for hMeDIP or 10 ml of
mouse monoclonal 5mC antibody (Eurogentec #BI-MECY-
1000) for 2 hrs, followed by addition of 40 ml of Protein A
Dynabeads (Invitrogen, #100.02D, hMeDIP) or Dynabeads M-
280 Sheep anti-mouse IgG (Dynal Biotech #112.01) added for
another 2 hrs. Immunoprecipitated DNA was amplified by 18
cycles of PCR following the Illumina Genomic DNA Sample
Preparation Guide and purified using the MinElute PCR
purification kit. Fragments of 250–300 bp (for single end
sequencing) or 400–450 bp (for paired end sequencing) were
size-selected from 2% agarose gel and purified using the
MinElute Gel Extraction Kit. Quality of the libraries and
template size distribution were checked on an Agilent 2100
Bioanalyzer (Agilent Technologies).
High-throughput sequencing
(h)MeDIP-seq and ChIP-BisSeq were sequenced using the
Illumina HiSeq 2000 as per manufacturer’s instructions.
Analysis of sequencing data
The hMeDIP-seq data were analyzed similarly to ChIP-Seq
data in Stadler et al. Briefly, the July 2007 M. musculus genome
assembly (NCBI37/mm9) provided by NCBI (http://www.ncbi.
nlm.nih.gov/genome/guide/mouse/) and the Mouse Genome
Sequencing Consortium (http://www.sanger.ac.uk/Projects/
M_musculus/) was used as a basis for all analyses. For reads from
hMeDIP-seq experiments, alignments to the mouse genome were
performed by the software bowtie (version 0.9.9.1) [57] with
parameters -v 2 -a -m 100, tracking up to 100 best alignment
positions per query and allowing at most two mismatches. Each
alignment was weighted by the inverse of the number of hits. All
quantifications were based on weighted alignments. Alignments
were shifted by 60 bases (estimated fragment length was 120 bp).
In order to identify regions with different signal in hMeDIP-seq
between ES and NP, the mouse genome was partitioned into 1 kb
sized windows with an overlap of 500 bp. For each window we
calculated log2 fold change between NP and ES using in the
following way: log2(FC) = log2((n_NP/N_NP *min(-
N_ES,N_NP)+p)/(n_ES/N_ES *min(N_ES,N_NP)+p)), where
n_ES and n_NP are the summed weights of overlapping ES and
NP read alignments, respectively. N_ES and N_NP are the total
number of aligned reads in ES and NP samples and p is a
pseudocount constant (p = 8) used to regularize enrichments based
on low counts that would otherwise be dominated by sampling
noise. Windows with log2(FC) bigger than 3 or smaller than 23 in
both biological replicates were merged into regions showing the
gain and loss of signal in NP, respectively. These regions were used
to calculate the enrichment in segment types (constitutive, ES- or
NP-specific LMRs, UMRs). Enrichments were calculated as the
ratio of observed over expected number of bases of each region
class (gain of signal in NP, loss of signal in NP) in a segment type
(e.g. ES-specific LMR etc.), where the observed number is the
number of bases in regions of a given class that overlap a segment
and the expected number is the fraction of genomic bases in that
segment type, multiplied with the total number of bases in all
regions of that class.
Analysis of ChIP-Seq and bisulfite (ChIP-BisSeq) data, ChIP
enrichment calculation and identification of CTCF binding sites
were performed as previously described (Stadler et al. 2011). The
data from the two CTCF ChIP-BisSeq replicates were pooled for
the analysis. Analysis of REST ChIP-Seq data and genome-wide
prediction of REST motifs was performed analogously to CTCF.
In the case of REST, the inferred weight matrix was extended to
allow for a variable linker (0–11 nts in length) after position 9.
Datasets used in this study
Datasets generated for this study, ChIP-BisSeq, hMeDIP-seq,
MeDIP-seq and RESTko methylome have been submitted to
GEO and are available under the accession number GSE39739.
Data for CTCF ChIP-Seq and WG-BisSeq was downloaded from
GEO: GSE30206 [7], data for REST ChIP-Seq were downloaded
from GSE27148 [58]. Tet1 ChIP-Seq data was downloaded from
GEO: GSE26833 [33].
Supporting Information
Figure S1 Genome-wide relation between transcription factor
occupancy and methylation states. (A) Correlation of ChIP
enrichments between CTCF ChIP-Seq (Stadler et al., Nature
2011) and the two CTCF ChIP-BisSeq replicates used in this
study. (B) Correlation of methylation levels at individual CpGs
between two CTCF ChIP-BisSeq replicates. Selected cytosines
have a minimal coverage of 10 in both replicates. (C) Correlation
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of average methylation levels at regions 200 bp around all
predicted CTCF sites between WG-BisSeq and a pool of both
CTCF ChIP-BisSeq replicates. Selected regions have a minimal
coverage of 10 in all cytosines used for the calculation of
methylation levels in both WG-BisSeq and ChIP-BisSeq. (D) For
individual cytosines within LMRs the methylation difference
between ChIP-BisSeq and WG-BisSeq is correlated with the
distance to the nearest CTCF motif center.
(PDF)
Figure S2 Relationship between binding strength and DNA
methylation within the CTCF motif. (A) CTCF consensus motif
used in this study. Here only cytosines are analyzed which are at
position 5–6 of the motif. Out of all predicted sites containing a
CpG within the motif (24.5% of all predicted sites) 42.2% have a
CpG at this position. (B–D) Each point represents one individual
CpG at position 5–6 of the PWM. (B) Correlation of methylation
and CTCF enrichment identifies three classes of CTCF sites:
unbound (light-blue), strongly bound and unmethylated (dark-
blue), weakly bound with intermediate levels of methylation (blue).
The red line represents a running mean measurement of
methylation. (C) Same as B, but only showing cytosines covered
in both WG-BisSeq and CTCF ChIP-BisSeq. (D) Same as C but
only showing methylation levels derived from CTCF ChIP-BisSeq.
In each case bound molecules show the same variation as the
entire population. Only cytosines residing within the CTCF
binding motif and with a minimal coverage of 106are shown. In
order to prevent over-plotting the points were jittered with a
standard deviation of 2%.
(PDF)
Figure S3 5hmC marks LMRs in a cell-type specific fashion. (A)
Replicate correlation for hMeDIP-seq. Shown is the log2 fold
change of 5hmC between ES and NP in two biological replicates.
(B) Correlation of hMeDIPseq and WG-BisSeq at LMRs during
neuronal differentiation. Shown are the log2 fold change in 5hmC
between ES and NP (y-axis) and change in DNA methylation
percentage (x-axis). (C) Correlation of hMeDIP-seq and MeDIP-
seq at LMRs during neuronal differentiation. Shown are the log2
fold change in 5hmC between ES and NP (y-axis) and change in
DNA methylation percentage (x-axis).
(EPS)
Figure S4 5hmC enrichment at CTCF sites 5hmC enrichment
at CTCF sites depends on CTCF binding. Shown are hMeDIP-
seq enrichments in ES cells over bound and unbound CTCF
motifs.
(EPS)
Table S1 Primer sequences used for qPCR.
(DOCX)
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56 Results 
Table S1. Primer Sequences used for qPCR 
Genomic 
region Forward  Reverse 
Camta GCTTCAGGGCTACAGAGTGC AGTCAGAGGCTACCCCTGGT 
Ciita GCAAGCTGGAGAAAAAGCAC TAGGATGAAGCCTGGGTGTC 
Crhr2 CGTGGCATTTATCGAAGTCA GTGGTCAGGAGCTCTCCAAG 
Zfp423 CATTTGCTTCTCCGCAGATT CATGTTTATGTCCGCTGCTG 
Muc3 CGGGTAGGAGACATCTCTGG CCAGAGAGATGATGCTGGAAG 
St6ga CTCTTCTCGGTCACCCATTC AATCACCCGCTGTGAATCAT 
A6300Rik CCCACGTCTCCATGGTTAAT TTCTGTGCGTGGCTAAACAG 
Zmynd8 GGCGTTTCCTTGATTGACAT AAGACAGGACCTGGAGGAGA 
Interg LMR CTTTGGCACACTGCCATCTA CCTTTTCATGAGACCCGAAA 
Interg3 ATGCCCCTCAGCTATCACAC GGACAGACATCTGCCAAGGT 
Hprt CCAAGACGACCGCATGAGAG CAACGGAGTGATTGCGCATT 
Gapdh CTCTGCTCCTCCCTGTTCC TCCCTAGACCCGTACAGTGC 
 
  
Results 57 
3.2 Quantitative analysis of DNA methylation turnover 
3.2.1 Abstract 
Transcription factor (TF) binding to specific distal regulatory elements, including 
enhancers and insulators, is crucial for the activation of the correct gene expression 
program that determines cell type identity (Takahashi and Yamanaka 2006). Upon 
occupying their target sites, TFs mediate changes in chromatin structure, which in some 
cases can facilitate the recruitment of additional factors (Zaret and Carroll 2011). Recent 
evidence from our and others’ work suggests that TF binding can mediate local 
hypomethylation events through triggering a turnover of DNA methylation at their binding 
sites (Stadler et al, 2011; Feldmann et al, 2013; Shen et al, 2013; Song et al, 2013). The 
specificity and consequence of this turnover for gene regulation as well as its 
mechanisms and kinetics are not well understood. 
Here we inactivate the de novo DNA methyltransferases DNMT3A and DNMT3B in 
embryonic stem cells. This setup prevents the addition of new methylation marks, thus 
allowing us to study the maintenance and turnover of DNA methylation exclusively. By 
using a technique allowing for high coverage single-base resolution methylation analysis 
of specific genomic loci, we show that simultaneous deletion of DNMT3A/B results in a 
loss of methylation at both low and fully methylated regions. Following methylation 
changes upon conditional inactivation of DNMT3A/B we are able to determine the 
precise methylation turnover kinetics for each individual CpG. This analysis reveals 
accelerated turnover at low methylated cytosines in comparison to fully methylated 
cytosines. 
In summary, we established a controlled system to study DNA methylation turnover. We 
show that DNMT3A/B-dependent turnover is present in embryonic stem cells. De novo 
DNMTs appear to be required for long-term maintenance of DNA methylation at both low 
and fully methylated regions. However, our data demonstrate that the turnover 
predominantly affects cytosines with low DNA methylation thus confirming the link 
between TF binding and DNA methylation turnover. 
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3.2.2 Global loss of methylation in DNMT3A/B double knockout 
embryonic stem cells 
We and others previously identified low methylated regions (LMRs) as sites of DNA 
methylation turnover (Feldmann et al, 2013; Shen et al, 2013; Song et al, 2013). Here we 
aimed to confirm its presence and further characterize it. 5-hydroxymethylcytosine is an 
intermediate of active DNA demethylation. Its further processing was reported to occur 
via facilitated passive demethylation (Valinluck and Sowers 2007; Inoue and Zhang 
2011) or direct removal with or without oxidation (He et al, 2011; Ito et al, 2011; Chen et 
al, 2012). A complete turnover cycle further includes remethylation. Such remethylation 
would take place independently of maintenance methylation. Maintenance by DNMT1 
requires a hemimethylated substrate DNA (Song J. et al, 2011; Song et al, 2012). Thus, 
we assumed that if the observed turnover is active it must depend on de novo DNA 
methyltransferase activity (Figure 3-1A). If this hypothesis is true and LMRs are indeed 
the main targets of DNA methylation turnover, embryonic stem cells lacking DNMT3A 
and DNMT3B (Dnmt3ab-/- ES cells) should retain wildtype methylation levels at fully 
(FMRs) and unmethylated regions (UMRs) but lose methylation predominantly at the 
LMRs.  
To test this model we compared DNA methylation levels between Dnmt3ab-/- ES cells 
(Okano et al, 1999) and the corresponding wildtype cell line J1 by a targeted bisulfite 
PCR approach (Figure 3-1B). We performed PCR on 90 different regions including 24 
FMRs, 52 LMRs and 11 UMRs, of which 65 amplicons were covered to at least 50% in 
both samples (for summary of all datasets see Table 3-1). For all covered amplicons we 
calculated average methylation levels and compared them between the two cell lines. To 
our surprise, we found demethylation at all of the analyzed regions in Dnmt3ab-/- ESC, 
regardless of their initial methylation status. Differences between segments were 
observed mainly in the extent of this demethylation. While UMRs and LMRs indeed are 
almost entirely devoid of methylation in Dnmt3ab-/- ESC, FMRs have heterogeneous 
methylation which spreads over the entire range from 0 to 80% (Figure 3-1C-D). Thus, 
we conclude that DNMT3A and DNMT3B are required for methylation maintenance at 
both LMRs and FMRs.  
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Figure 3-1 Site-specific demethylation in Dnmt3ab-/- ES cells. 
(A) In this experiment we tested the dependency of DNA methylation turnover on de novo DNA 
methyltransferases DNMT3A and DNMT3B (DNMT3). (B) Methylation was analyzed using a 
targeted bisulfite PCR approach, in which regions of interest, residing within LMRs, UMRs or 
FMRs were amplified from bisulfite converted DNA and subjected to sequencing on the MiSeq 
platform. (C and D) Fragment methylation was calculated over all cytosines within a fragment 
covered at least five times in the sequencing sample (C) Comparison of average methylation 
levels of targeted amplicons between Dnmt3ab-/- ES cells and the corresponding wildtype ES 
cells J1. All wildtype unmethylated (green) and almost all low methylated fragments (red) are 
entirely devoid of methylation in DNMT3ab-/- ES cells. Fully methylated fragments also lose their 
methylation in Dnmt3ab-/- ES cells to a varying degree. (D) Boxplots summarizing changes in 
DNA methylation between Dnmt3ab-/- and J1. Shown are only fragments overlapping with FMRs 
and LMRs according to segmentation from Stadler et al. (Stadler et al, 2011). Note that all 
fragments display a loss of methylation in Dnmt3ab-/- ES cells. Loss of methylation was 
calculated as fraction of methylation loss relative to the wildtype methylation levels (left) and as 
absolute loss in percentage methylation (right). Note, that while Dnmt3ab-/- ES cells on average 
lose more than 80% of their starting methylation at the LMRs, their absolute loss only comprises 
20% methylation and is smaller than the absolute loss of methylation at FMRs. Boxes show the 
interquartile range and the median.  
To determine whether the turnover is faster within LMRs, we calculated the loss of 
methylation at LMRs and FMRs using two different methods (Figure 3-1D). As expected, 
comparison of demethylation normalized to original methylation levels revealed a higher 
degree of demethylation at LMRs which lost almost 100% of their initial methylation 
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(Figure 3-1D, left). On the other hand, absolute loss of methylation (i.e. the difference 
between Dnmt3ab-/- and J1 methylation) is higher at tested FMRs (Figure 3-1D, right). 
This precludes a direct comparison between the two types of segments.  
It is important to note that ES cells used for this experiment have been cultured for 22 
passages following deletion of DNMT3A and DNMT3B. Assuming that ES cells divide 
every 12-18 hours and are transferred on a new plate every second day (Bibel et al, 
2007), they underwent up to a hundred cell divisions by the time the experiment was 
performed. This prevents us from drawing conclusions on the timing or kinetics of 
demethylation at different types of segments. 
In summary, our results indicate involvement of DNMT3A and DNMT3B in long-term 
methylation maintenance at both low and fully methylated regions. However, methylation 
profiling in stable knockout ES cells does not allow us to ask at which sites the observed 
demethylation is initiated. 
3.2.3 DNMT3A/B dependent DNA demethylation at active 
regulatory regions 
We reasoned that conditional deletion of DNMT3A/B in an ES cell line would allow us to 
determine the kinetics of demethylation. Therefore, we took advantage of conditional 
embryonic stem cells. This cell line was derived from mouse embryos containing loxP 
sites which flank the exons of catalytic domains in both alleles of Dnmt3a and Dnmt3b 
(Dodge et al, 2005). Conditional inactivation of DNMT3A/B was achieved by direct 
transduction of the HTN-Cre (His-TAT-NLS-Cre) protein (Figure 3-2A). HTN-Cre is 
tagged with a peptide derived from the human immunodeficiency virus (HIV) 
transactivator of transcription (TAT) protein and can directly permeabilize the cell 
membrane (Peitz et al, 2002). The advantage of this method is a fast response and a 
complete lack of leakiness.  
Recombination efficiency was measured four days after the transduction by quantitative 
genotyping and was on average 89.5% and 83.9% for Dnmt3a and Dnmt3b, respectively 
(Figure 3-2B). When we compared methylation at individual cytosines between ES cells 
transduced with Cre and control cells, we found that indeed inactivation of DNMT3A/B 
led to a mild decrease of methylation after four days. Importantly, the loss of methylation 
was limited to cytosines with low to intermediate methylation levels (Figure 3-2B, day4).  
Encouraged by these results, we decided to perform a time course over 15 days. 
Approximately 10-15% of ES cells in the analyzed population still contained intact  
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Figure 3-2 Conditional inactivation of DNMT3A/B in ES cells. 
(legend continues on the next page) 
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Figure 3-2 Conditional inactivation of DNMT3A/B in ES cells. 
(A) Upper panel: schematic representation of the conditional deletion alleles for Dnmt3a (yellow) 
and Dnmt3b (green). LoxP sites (black triangles) flank one catalytic exon of the Dnmt3a allele and 
four of the Dnmt3b allele. The ES cells are homozygous for loxP sites in Dnmt3a and Dnmt3b 
genes. Please, note that the distances are not true to scale and by far not all exons are presented 
here. Upon transduction of the HTN-Cre protein the regions flanked by loxP sites are deleted. 
Bottom panel: the amount of intact alleles in total population of cells was quantified by TaqMan 
PCR 4, 8, 10, 13 and 15 days after transduction of Cre. Average of two biological replicates is 
shown. The error bars represent standard deviation. Mock: negative control transduced with Cre 
buffer alone. (B-D) Only CpGs with coverage of at least ten fold in all presented samples are 
shown. (B) Correlation of methylation between Cre (+Cre) and corresponding mock transduced (-
Cre) conditional knockout ES cells at indicated time points after transduction. Each point 
represents a single CpG. (C) Absolute loss of methylation relative to the reference sample (mock 
at day 4) for each time point. For this plot the CpGs were subdivided into fully methylated (60-
100% methylation in the reference sample, blue) and low methylated (10-60% methylation in the 
reference sample, red). The boundaries of the boxes represent the interquartile range and the 
middle line shows the median. (D) Correlation of methylation between Cre (+Cre) and mock 
transduced (-Cre) J1 cells. Each point represents a cytosine within a CpG dinucleotide. Note that 
the level of demethylation achieved after 15 days is much smaller than for the conditional 
knockout ES cell line. 
 
Dnmt3a/b alleles four days after the Cre transduction. However, these cells do not have 
a growth advantage in our time course, since the proportion of Dnmt3ab-/- ES cells 
remained stable and even increased mildly during culturing (Figure 3-2A).  
Methylation analysis of the 474 cytosines covered at least ten times in all samples 
showed that low methylated cytosines started to progressively demethylate before day 
four after the transduction of Cre. A plateau was reached at day ten, when presumably all 
methylation was lost from these regions (Figure 3-2B-C). Cytosines with 60-100% 
methylation, characteristic of fully methylated regions, started to progressively 
demethylate between day four and day eight post-transduction. This suggests a better 
capability to maintain their methylation in the absence of DNMT3A/B activity. After 13 
days, absolute loss of methylation at fully methylated cytosines almost reached the level 
observed at low methylated cytosines (Figure 3-2C). Importantly, the effect on DNA 
methylation was specific to Cre-induced deletion, as Cre transduction in the wildtype cell 
line J1 did not cause strong demethylation even after 15 days (Figure 3-2D).  
We considered the possibility that an increase in the fraction of cells with a deletion in 
Dnmt3a/b throughout the time course might explain the observed demethylation (Figure 
3-2A). Assuming that each Dnmt3ab-/- cell is fully unmethylated and replaces a fully 
methylated cell in the total population, this would account for a maximum of 5% change 
in methylation over the time course. This is below the observed changes in methylation 
and thus does not affect the here measured methylation. Our results from individual 
CpGs suggest that the turnover is faster at cytosines with low methylation levels. 
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Analysis of methylation changes within single amplicons across the time course 
extended our observations from single cytosines to entire regions. While UMRs had 
stable methylation in ES cells transduced with HTN-Cre, LMRs and FMRs both displayed 
demethylation. We furthermore note that in the absence of Cre ES cells tend to 
upregulate their methylation probably as a consequence of prolonged feeder-free 
culturing (mock in Figure 3-3, and data not shown).  
 
 
Figure  3-3 Time course of Cre transduction and Mock transduction in representative 
amplicons. 
Note that LMRs and FMRs display high demethylation only upon Cre transduction (Cre +). Some 
cytosines upregulate their methylation during culturing in the absence of Cre (Cre-). Reference 
sample for both representations is mock transduction at day four (mock4). The nature (cre/mock) 
and duration in days (4-15) of the treatment are indicated below the panels. Vertical lack lines 
mark the position of single CpGs. Red shade: Position of the LMR, green shade: position of a 
bound CTCF motif. Only cytosines with at least ten fold coverage in all samples are shown. 
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We asked whether demethylation of a region occurs homogenously or whether it is 
initiated by certain cytosines. Our targeted PCR approach allowed for analysis of up to 
300 basepair long reads thereby enabling us to determine the similarity between 
cytosines at each time point and detect co-regulatory patterns. This analysis revealed 
that the heterogeneity in methylation is generally low throughout the time course. Thus, 
even if demethylation is pioneered by a single cytosine this is not detectable by the here 
applied resolution (Figure 3-4). 
Together, we confirmed the presence of a DNMT3–dependent turnover at low 
methylated regions. However, in contrast to our expectations, this turnover also affects 
regions with full methylation. 
 
 
Figure  3-4 Heterogeneity analysis for CpGs within a representative LMR. 
Shown are average methylation for each single cytosine (blue bars in the upper panel) and 
similarity between cytosine pairs (heatmaps). For each pair of CpGs the similarity in methylation 
was calculated as fraction of reads in which the two cytosines have the same methylation state. 
Note that the similarity between CpGs never drops below 0.5 and correlates with the degree of 
demethylation. There is furthermore no focal demethylation detectable.  
 
3.2.4 Unbiased turnover quantification reveals its predominant 
targeting to cytosines with low methylation 
For a better comparison between different types of regions, we next aimed to directly 
quantify the turnover kinetics and relate it to the level of starting methylation. Therefore, 
we first determined the methylation decay rate for each individual cytosine in the sample 
(for details see 3.2.5). To ensure that our methylation measurement is robust, only 
cytosines covered at least a 100 fold in all samples were considered for this analysis. We 
performed a non-linear regression for each CpG, assuming an exponential decrease in 
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methylation (Figure 3-5A). To test whether inferred parameters approximate our 
measurements, we first correlated the measured methylation with the inferred 
methylation met(t0) for each cytosine at each time point in the time course (Figure 3-5B). 
This revealed a very high correlation (r=1 and r=0.98 for replicate 1 and replicate 2, 
respectively), suggesting a high accuracy of the estimated parameters.  
 
 
Figure 3-5 Determination of methylation turnover rate 
(A) Shown are methylation levels for one representative CpG across the time course. For each 
cytosine a non-linear regression was performed assuming exponential methylation decay. 
Methylation at time point t=0 (met(t0)) and the turnover coefficient ß were estimated. Only CpGs 
covered at least a 100 times were used in this analysis. (B) Methylation for each cytosine and 
each time point was calculated using met(t0) and ß estimated in A. This inferred methylation rate 
was correlated with measured methylation for two biological replicates. Each point represents one 
CpG at one time point during the time course. (C) Correlation of turnover rates (for calculation see 
3.2.5) between the two biological replicates. Cytosines with a starting methylation below 10% and 
a methylation below 5% at four days after Cre transduction were omitted. Each point represents 
one cytosine. 
 
Next, we asked whether the observed turnover is reproducible across biological 
replicates. For cytosines below 10% methylation accurate determination of decay rate 
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cannot be achieved, as a small methylation change would introduce noise in turnover 
estimation (Figure 3-3 and data not shown). This noise is illustrated in the high spread of 
turnover rates observed between these cytosines (Figure 3-7). Furthermore, the mean 
variance of cytosine turnover within UMR amplicons is more than six times higher than 
the average turnover variance between UMR fragments (8 x 10-3 and 1.3 x 10-3, 
respectively). Similar to UMRs, our approach is not suitable for cytosines with a very fast 
turnover like those entirely losing their methylation four days after Cre transduction. For 
these cytosines the exact time point of full demethylation cannot be determined and thus 
their turnover rates would be underestimated. Therefore, we excluded all cytosines with 
a methylation below 10% at the starting time point and below 5% four days after Cre 
transduction from further data analysis. For the remaining 168 cytosines covered at least 
100 fold in all time points in both experiments we correlated turnover rates from two 
biological replicates. This revealed a correlation of 0.92, suggesting that the turnover is 
reproducible (Figure 3-5C, 3-6B). We note, however, that despite this generally high 
correlation some spread persists for cytosines with a fast turnover. 
 
 
Figure 3-6 Relationship between turnover rate and methylation. 
(A) Correlation of turnover rate with methylation reveals higher turnover rates at low methylated 
cytosines. Shown is the mean turnover rate between two biological replicates. Each point 
represents one CpG. Only CpGs with coverage of at least 100 in both replicates are shown. 
Cytosines with a starting methylation of below 10% and methylation of below 5% four days after 
Cre transduction were omitted. (B) Turnover rate (upper image) and starting methylation (bottom 
image) in a representative LMR. Blue and red lines show replicate1 and 2, respectively. Black line 
represents the mean turnover rate of two replicates. Vertical black lines mark CpG positions within 
the amplicon. Red shade marks the position of the LMR according to previous segmentation 
(Stadler et al, 2011). Green shade: position of a bound CTCF site. For each replicate only CpGs 
with coverage of at least 100 are shown.  
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Having this quantitative readout, we decided to reevaluate the relationship between the 
turnover rates and the starting methylation level of analyzed cytosines. Indeed, within our 
data-set high turnover rates occur at cytosines with low starting methylation levels, while 
turnover rates at fully methylated CpGs linearly increase with decreasing methylation 
(Figure 3-6A). Importantly, this observation is not limited to cytosines residing in different 
regions, as CpGs within the same genomic region can readily differ in their turnover 
rates (Figure 3-6B). Overall, little difference was observed in the variance of turnover 
within and between regions (2.33 x 10-3 and 2.00 x 10-3, respectively). 
 
 
Figure 3-7 Turnover rates within different segments 
Turnover rates at all analyzed CpGs (white), CpGs within FMRs (blue), UMRs (green) and LMRs 
(red) for all individual cytosines covered at least 100 times. Note that constitutive FMRs (light 
blue, left) do not display lower turnover than NP-specific LMRs which are FMRs in ES cells (light 
blue, right). The strong almost uniform variation in turnover at UMRs probably reflects 
measurement limitations at very low methylated cytosines. Note that cytosines within FMRs 
flanking LMR regions (purple) generally have a higher turnover rate than average FMRs (blue). 
Boxes show the median and the interquartile range. 
 
Comparison of methylation turnover rates at all analyzed cytosines which reside within 
LMRs, FMRs or UMRs furthermore shows that turnover is fastest within LMRs (Figure 3-
7). Interestingly, FMRs directly adjacent to LMRs in our dataset display enhanced 
turnover kinetics, suggesting that their methylation could be influenced by TF binding 
within the LMR regions. No increased methylation turnover could be detected at cell type 
68 Results 
specific FMRs which have high hydroxymethylation in neuronal progenitors (NP- LMRs 
in Figure 3-7) as compared to constitutive FMRs (Constitutive FMRs in Figure 3-7). 
In summary, unbiased quantification of turnover reveals its accelerated kinetics at low 
methylated regions and individual low methylated cytosines. 
 
dataset total reads conversion 
efficiency [%] 
protection 
efficiency [%] 
CpGs Fragments
cov>9 cov>9 
3ab -/- ESC rep1 5415260 98.1 97.6 509 82 
3ab -/- ESC rep2 6165442 99.5 99.9 431 69 
J1 ESC rep1 5687936 98.2 97.7 525 82 
J1 ESC rep2 6368876 99.7 100.0 419 70 
CreTD1-d4 15440206 97.8 99.4 502 79 
CreTD1-d8 3733392 99.8 99.9 479 75 
CreTD1-d10 3728962 98.1 99.7 478 76 
CreTD1-d13 4174414 99.3 99.8 476 75 
CreTD1-d15 3787318 99.1 99.8 500 80 
CreTD2-d4 3358126 99.3 100 447 72 
CreTD2-d8 3234086 98.6 99.9 520 81 
CreTD2-d10 3245980 98.4 99.9 480 77 
CreTD2-d13 2838246 92.3 99.9 480 77 
CreTD2-d15 2837296 97.9 99.6 495 78 
MockTD1-d4 10003876 99.4 98.2 503 79 
MockTD1-d8 4049724 73.5 95.8 504 80 
MockTD1-d13 4005596 97.0 99.8 496 79 
MockTD1-d15 3194158 99.8 99.6 521 82 
MockTD2-d4 3246084 98.8 99.8 495 79 
MockTD2-d8 4248638 99.1 99.9 532 82 
MockTD2-d10 2723552 95.1 99.9 490 78 
MockTD2-d13 2931254 98.5 97.4 509 80 
MockTD2-d15 2923594 98.3 98.9 486 76 
CreTD-J1-d4 3309530 99.3 99.9 508 79 
CreTD-J1-d15 3778564 94.8 99.6 515 79 
MockTD-J1-d4 3383836 97.5 99.9 503 79 
MockTD-J1-d15 2923594 97.5 99.9 501 78 
 
Table 3-1 Summary of all datasets used in 3.2 
TD1: transduction replicate 1; TD2: transduction replicate 2; ESC: embryonic stem cells; d: day; 
3ab-/-: Dnmt3ab-/-; rep1/2: replicate1/2; Cre: cre transduction; Mock: control transduction with Cre 
buffer; cov: coverage  
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3.2.5 Materials and Methods 
Targeted amplicon sequencing 
Genomic DNA was isolated from ES cell pellets. For elimination of feeders, the 
trypsinized ES cell-feeder mix was allowed to settle on a plate for 20-30 minutes before 
collecting the supernatant. Genomic DNA was isolated as previously described (Mohn et 
al, 2009). Briefly, cell pellets were resuspent in TE and equal volume of lysis buffer 
containing 20µl of proteinase K (10mg/ml) prior to incubation for at least 5hrs at 55°C. 
DNA was phenol-chloroform extracted, precipitated with ethanol containing 75mM 
sodium acetate pH5.2, washed in 70% ethanol and the pellets allowed to dry at RT for 5-
10 minutes. Extracted genomic DNA was resuspent in TE buffer containing 20µg/ml 
RNAse A and incubated for 30min at 37°C while slowly shaking. DNA concentration was 
determined using Nanodrop (ND-1000 Spectrophotometer, Witec AG), a mean of two 
measurements was taken. 2-14µg of genomic DNA were spiked with unmethylated 
lambda DNA and in vitro premethylated T7 DNA (1.6pg/µg DNA) and bisulfite converted 
according to the manufacturer’s protocol of the EpiTect Bisulfite kit (QIAgen, #59104), 
using 1-2µg per conversion reaction. The conversion reactions from one genomic DNA 
were pooled and used for targeted bisulfite PCR. Targeted bisulfite PCR was prepared in 
a 96-well plate format with primers described in Table 3-5. For one 25µl reaction mix 
1/105 of the converted genomic DNA were mixed with 5µl of a 2µM mix of forward and 
reverse primers, 2.5µl 10x PCR buffer, 1.25µl DMSO, 1.5µl of 25mM MgCl2, 1.5µl of 
2.5mM dNTPs and 0.25µl of 5U/µl AmpliTaq Gold polymerase (Applied Biosystems, # N-
8080249) and subjected to PCR according to Table 3-1. Equal volumes of each 
amplicon were pooled and 100µl of the total mix extracted from a 1.5% agarose gel.  
Libraries from extracted amplicon PCR mix were prepared according to the 
manufacturer’s protocol for NEBNext ChIP-Seq Library Prep Master Mix Set for Illumina 
(New England BioLabs, #E6240) for multiplexed libraries. Briefly, the concentration of 
each sample was measured using NanoDrop 3300 Fluorospectrometer (Witec AG). The 
samples were end-repaired, dA-tailed and adapter ligated using NEBNext Multiplex 
Oligos for Illumina (New England BioLabs, #E7335). Following this they were size 
selected using Agencourt AMPure XP beads (Beckman Coulter, # A63880) and PCR 
amplified for 12 cycles using appropriate indexed primer for each adapter and cycling 
conditions according to Illumina recommendations. Adapter-ligated and amplified DNA 
was eluted using AMPure XP beads, the size distribution was analyzed on Agilent 
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Bioanalyzer 2100 using Agilent High Sensitivity DNA kit (Agilent technologies, #5067-
4626). For multiplex sequencing, libraries were pooled in an equimolar ratio. 
Sequencing was performed on Illumina MiSeq, using MiSeq v2 reagent kits 300bp PE 
(Illumina, #MS-102-2002) according to Illumina recommendations.  
 
Step T [°C] t [min:s] 
1 95 09:00 
2 95 00:30 
3 55 to 51 00:30 
4 
decrease by 0.2°C each 
cycle 
5 72 00:30 
6 repeat steps 2-4 19x 
7 95 00:30 
8 51 00:30 
9 72 00:30 
10 repeat steps 7-9 35x 
11 4 hold 
Table 3-2 Bisulfite PCR conditions 
 
Cre protein transduction 
ES cells were cultured as previously described (Bibel et al, 2007), passaged at least 
once on feeders prior to trypsinization for Cre protein transduction. Transduction was 
performed as described (Haupt et al, 2007). Briefly, ES cells were trypsinized, resuspent 
in PBS and quantified. 2.5 x 105 cells were transferred into fresh falcon tubes, spinned 
down and resuspent in 500µl of filtered serum-free medium (Table 3-2) containing either 
2µM Cre protein or an equivalent volume of Cre dialysis buffer (2M NaCl, 50mM HEPES 
pH7.4, 1mM DTT, 1mM EDTA and 5% Glycerol). The cells were plated in 24-well plates 
pre-coated with feeders and washed twice with PBS. After 16hrs cells were washed 
twice with PBS and coated with FCS-based ES medium (Bibel et al, 2007). ES cells 
were transferred to gelatin-coated 6-well plates 24hrs and to 10cm plates 72hrs after 
transduction. Pellets were collected from trypsinized cells at indicated time points and 
culturing was continued until 15 days post-transduction in feeder-free environment. All 
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ES cells used for Cre transduction experiments have been cultured in total for five to 
seven passages prior to Cre transduction. 
 
Reagent Company Cat.-No Stock conc. End conc. 
DMEM/F-12 with 
HEPES Life Technologies 31330-038 1x 0.5x 
Neurobasal Life Technologies 21103-049 1x 0.5x 
N2 supplement Life Technologies 17502-048 100x 1x 
B27 supplement Life Technologies 17504-044 50x 1x 
MEM Non-Essential 
amino acids Life Technologies 11140-050 10mM 100µM 
L-glutamin in house preparation   200mM 2mM 
ß-mercaptoethanol Sigma M6250 100% 0.01% 
LIF in house preparation   - - 
Table 3-3 Serum-free medium composition 
 
Quantitative genotyping 
TaqMan primers and probes were designed using the Primer Express software (Applied 
Biosystems, v3.0.1) to detect genomic DNA between the two loxP sites and are listed in 
Table 3-6.  
Genomic DNA was diluted to 30ng/µl and subjected to singleplex quantitative PCR using 
the StepOne Plus cycler (Applied Biosystems) according to conditions described in 
Tables 3-3 and 3-4. Each PCR was performed in triplicates. For the analysis the amount 
of template DNA for each PCR was quantified using the absolute standard curve and 
normalized to Gapdh as reference template. Amount of molecules with intact catalytic 
exons of Dnmt3a and Dnmt3b was quantified relative to genomic DNA from untreated 
cells collected at the same time points. Standards with 100%, 20% and 0% of floxed 
Dnmt3a and Dnmt3b genomic DNA mixed with genomic DNA from an ES cell clone with 
fully deleted alleles were quantified as controls in each experiment.  
 
 
72 Results 
reagents 
starting 
concentration 
(nM) 
final 
concentration 
(nM) 
Volume (µl) 
per well 
TaqMan Universal PCR 
Master Mix (Applied 
Biosystems, # 4304437) 
2x  1x 12.5 
Fwd and Rev primer mix 50000 900 0.45 
TaqMan probe 10000 250 0.625 
DNA sample 30 ng/ul 75 ng 2.5 
ddH2O   - 8.925 
total   - 25 
Table 3-4 TaqMan PCR reaction mix 
 
Step T [°C] t [min:s]
1  50 02:00 
2  95 10:00 
3  95 00:15 
4  60 01:00 
5  repeat 3-4 40x   
Table 3-5 TaqMan PCR conditions 
 
Data analysis 
The M. musculus genome assembly from July 2007 (NCBI37/mm9) provided by NCBI 
(http://www.ncbi.nlm.nih.gov/genome/guide/mouse/) and the Mouse Genome 
Sequencing Consortium (http://www.sanger.ac.uk/Projects/M_musculus/) was used as 
reference genome for all alignments. Alignment of bisulfite sequencing reads was 
performed using the software package Bismark v0.6.beta2 (Krueger and Andrews 2011) 
together with Bowtie-0.12.7 (Langmead et al, 2009) with the following parameters: -n 3 --
non_directional. Sequencing data generated for read 1 and read 2 were aligned 
separately. Methylation was extracted by Bismark v0.6.beta2 methylation extractor with 
the parameters --comprehensive –s. Conversion efficiency of unmethylated and the 
protection efficiency of methylated CpGs were determined by quantification of 
methylation obtained from spiked-in unmethylated lambda and methylated T7 DNA, 
respectively (see Table 6-1). To ensure that only fully converted reads are taken into 
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account for the analysis, the conversion efficiency of non-CpGs within each read was 
required to be at least 80% to pass the filter. Absolute loss of methylation was calculated 
as a difference between Dnmt3ab-/- and corresponding wildtype methylation 
(met(Dnmt3ab-/-) - met(wt)). Relative loss of methylation was calculated as 
(met(Dnmt3ab-/-) - met(wt)) / met(wt). For similarity analysis for each pair of cytosines 
the similarity score was quantified as fraction of reads with equal methylation for these 
two cytosines: reads(equal methylation) / reads(total).  
Quantification of turnover kinetics 
The turnover was quantified in R version 3.0.2 (R Core Team (2013). R: A language and 
environment for statistical computing. R Foundation for Statistical Computing, Vienna, 
Austria. URL http://www.R-project.org/) using non-linear regression and assuming an 
exponential decay after observation of all data points. For each cytosine covered at least 
a 100 times in the datasets a curve was fitted for the equation met(t) = met(t0) x etß, 
where t is the time after Cre transduction in days, met is the methylation and ß the 
turnover coefficient. As reference methylation, the methylation of mock transduced ES 
cells at t=4 was taken to ensure reproducibility between replicates. The turnover 
coefficients were estimated for each time course for Cre (ßCre) and the Cre dialysis buffer 
(ßmock) transduced samples. Final turnover rates were calculated by normalizing the 
turnover coefficients to respective Mock samples and multiplication by -1 to obtain 
positive turnover rates: (-1) x (ßCre - ßmock). 
Additional Materials  
 Multiplate PCR plates 96-well clear (BioRad, #MLP9601) 
 PCR salers Microseal ‘B’ Film (BioRad, # MSB1001) 
 PCR machines: C1000 Touch Thermal cycler/iCycler (BioRad) 
 MicroAmp Fast Optical 96-well reaction plate (Applied Biosystems, # 4346906) 
 MicroAmp Fast Optical Adhesive Film (Applied Biosystems # 4311971) 
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Oligonucleotide sequences: 
Region Forward Primer Reverse Primer 
FMR1 AGTTGTTAGGATTTGAATTTTGGT CCTCTACTCCTTCTTTCCTAATACA 
FMR2 AGGATGGATGTGTTATGTTTTAGT AAATCTACCTTTCCTTCCAACA 
FMR3 TTTTATTGATTGTTATGTGGTGTTTT ACAACTCCTCTTCTCCAACA 
FMR4 AGATGTTTGTTTAGTTTTGGGTT CCAAAACCCTAACAATCCCC 
FMR5 GGGAGGTAGGGGTAGTAAGA ACACACACACACACACAATA 
FMR6 AGAGATTGGTGGGTTGGATT ACCACCACAAAACAAATACCT 
FMR7 GGGAAGTTGAGGTAGGTAGG CAACCAACCAACCAAAACCT 
FMR8 GGGTTTTGTAGGGTGTGAGA CCACTACCACATCACAATTCC 
FMR9 AGTGGAGTGGTGTAGAGGAT ACCTTAAACCTCTCTCAAAACA 
UMR1 GGTTTTGATGGTTGAGGTGT TTCCCAATCCCCATTTCTCC 
UMR2 AGGATTGTTTGGGATGGAAAA CAAACTCAACCCAACCAACC 
UMR3 AGTTAAAGAATGAAATTGAAGTTTGAA TCCTCTTCATTTTCCCCATCT 
UMR4 AGGGATTAGTAGGAAAGGAGTT CACCTTCCACCCCTCTATTA 
UMR5 AGGTATGAGAGTTAGAAATTAAGAGG AACAACTATACCCACAAATCTCT 
UMR6 GTTTTGGTATTTAAGAAAGGTTAGGG AATTCCCCAACCATTCACCT 
UMR7 GGGATTGTTGGGAGGGATAG CCAAAACAACCAAAACTACACA 
UMR8 AGGAGTTAATGAGGGAGAATAAGA AAACCCCTCCTCCAAAACTC 
UMR9 AGTTTTGGTTAATGAAGTAGGAGA CCCTCATTCCTAACCCCAAT 
UMR10 TGGAGGGGAAAAGGGAAAAT ACACAACAACTACATCAACTAAACT 
UMR11 AAGGTTTTGAGGTAATTGAGTGA TCCCATCTATCTCCTCCACC 
metIsland1 GTTGTTAGGGTTAGGTTTTGATT TCCTATTACTCCCAACAATACCA 
Methylated_UMR1 TGGGGTAGAAAAGTTGTTTAGT ACCACCAAACATAACACACA 
Methylated_UMR2 TGTGGGAAAGGTAGTAATAAAATAGA AACCAACAAACTATCTCATACCA 
DMR1 GATTTGGTGGTTGGGAGTTG AAACTAAACAAACCACCTCAAAA 
DMR2 GGTTTTAGAAAGTTGTTTTATTTTGGG TTCACATCAAAACAACACCTCA 
DMR3 AGATGGTGATAGGGGAGAAAA TCACCCAAATTCAATACCTCAA 
ES-specific_LMR1 GGTGGAGGTGGTTTAAAGGT TACCCAAAACCACCCTAACC 
ES-specific_LMR2 TTTAAGATAAGTTGTTGTTGGGTT TCCTAACCAAAATCCTAAATACCT 
ES-specific_LMR3 TGGGATTTGAGATTGTATTAGTTAGG CAAAACAAATCCCTATCCTCTAAC 
ES-specific_LMR4 GGGGTTGGGTAATAGATGGT ACAATCACACATCAAACCCT 
ES-specific_LMR5 TTGTTATTAAGTTGGAGTGGGT CCATCCACTTATCTCCCACA 
ES-specific_LMR6 GGTAGAGTGTTTTAGTTAAATTAAGGG AACTACCATCCATCCACTCC 
ES-specific_LMR7 AGTGTTTAGGTGTATATTAGGAGGT ACAAAACCCTACCTACTCCT 
ES-specific_LMR8 AGGGAGATGATAGATTAGGTGAT ACCTTCCACTATCCCTACTCA 
ES-specific_LMR9 ATTATGTGAGTTAAGATGGGTGT ACATAAACTTACTTAACCTTATACCCA 
NP-specific_LMR1 GGGAGGTAGAGTTGGATTAGTAAA ACTCCCTATTACCAACTACAATTT 
NP-specific_LMR2 TGAGTGGTTTTGTTTGTGAGG ACTCCCAAACTTTCTTCTATCAC 
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NP-specific_LMR3 TGTTGGAAGTTGATATATTGTAGTTGA ACCTCAAACTCAACTCACACT 
NP-specific_LMR4 TGGTTTTAGTTTAAGAAAAGGAAAGT TTCACTTCATTTACTCCTCTCTT 
NP-specific_LMR5 TTGGAGGGAGTAGGGGAG ACCCAATCAACAATATTACATATCCA 
NP-specific_LMR6 GGTTGAGTTTAAATAGAGGTTAGGG ACTTCTATTTCCACTAAACCTACA 
NP-specific_LMR7 AGAGTAAGGTTTTGAGGTGAGT CCCAACCTCTTAACTTCCCA 
NP-specific_LMR8 TGATGGGAGAGAAAGAGTGAG ACTCTCCAATTCATTTAATAAAACTCT 
NP-specific_LMR9 AGGTTATTTTAGAGGTTTGTTAGGT ACATCACAAACCCTTTTCAAAA 
NP-specific_LMR10 TGTGAGAAGGTAAGAGGTGTG CCTATCAAACTAACCAACTACCT 
NP-specific_LMR11 AGGTAGTTGGTTAGTTTGATAGG ACAAAACAAAACAATACCAACCA 
NP-specific_LMR12 TGGTTGAGTAATGAGATAGGTTT ACCCCATAATTATCTCAAATCTCA 
Constitutive_LMR-CTCF1 TGTTTTGGTATGAAAGTTTTGGT CCTCAACCTAACCTAAACCCA 
Constitutive_LMR-CTCF2 AGTTTTGTTTTGTATTTGGTTGTTAA ACTCAATCATTTCCATTCCAAAA 
Constitutive_LMR-CTCF3 TGGGGAGGGATGTGGTATAA ACTTCACTTCCACCTAAAACTT 
Constitutive_LMR-CTCF4 TGGGAGAGGAAGTGTGTTTT ATCAACAACCACCTCCAAAA 
Constitutive_LMR-CTCF5 AAGGTAAGTTTGATTTAGAGAATTGA ACCACTATCCAAACCCAAACT 
Constitutive_LMR-CTCF6 AATAGTAGAGGTGGATTTGATTATAGA CAAACCACACTAAACCTCACA 
Constitutive_LMR-CTCF7 GGTTATGTTATTGTAGTGAGTGGT ACTCTCAACAACCAATACTCCA 
Constitutive_LMR-CTCF8 GGTTATGTTATTGTAGTGAGTGGT ACTCTCAACAACCAATACTCCA 
Constitutive_LMR-REST1 TGTAGTTTGGAATTAGAAGTGTTATT CTCTAAATCTAAACTCTCTATTCAACA 
Constitutive_LMR-REST2 AGAGAGTTGAGATTAGAGGGGA ACTCAACTCCACAACCAAAC 
Constitutive_LMR-REST3 TGTTAGGAGTGTAATAGTTAAGTGG ACCAAAATTCAAACCCCAACA 
Constitutive_LMR-REST4 GGGGTAGTAAGATAAATAGTAGGGA TCTAACTACATAACCTCAAACCAA 
Constitutive_LMR-REST5 AGTGTTGGTAGTAGGTATTGGT ACCTCTAATAACAAAATTACTCAACA 
Constitutive_LMR-REST6 TTTAGGATTAGGGATAGTAGTAAAGTT ACCTTCCAACTCCCAAACAT 
Constitutive_LMR-REST7 GAATTGTAGGGAAAAGGTGAGT ACACCTCAAATTTCAACACCA 
Constitutive_LMR-REST8 AAGTTTGTTAAAATGAGATTAGGATTG ACCTATTATAAACTCCAACCTACAA 
Constitutive_LMR-REST9 AGGATGGTGTTGAAAATTGTTATT CCCTACTTATAATACTCCTTAAACAAA 
Constitutive_LMR-REST10 TTGGGGAAGGTTTGTTGGTT CTCTCTCAACCTTACTTCCAAAA 
Constitutive_LMR-REST11 GTGGAGATAATTGTTTTAGTGTTTGA ACCACAACTAACATTCCCCA 
Constitutive_LMR-REST12 TTGGGGAAGGTTTGTTGGTT CTCTCTCAACCTTACTTCCAAAA 
Constitutive_LMR-REST13 TGTTGTATTTTGGTTTAGTGGTTTG ACACCTAAACTTTCAATCAACCA 
Constitutive_LMR-REST14 TGGTTAGGGGTAAGGTTGTG AACCACAAACCCAACAATCC 
Constitutive_LMR-REST15 AGAATTGTAGGGAAAATGTGAGT CCACACCTCAAATTCCAACA 
Constitutive_LMR-REST16 GTGGAGATAATTGTTTTAGTGTTTGA ACCACAACTAACATTCCCCA 
Constitutive_LMR-REST17 GGAATGGTTTTGGTTGAGGT CCAATACCTACCAAACAACCA 
Constitutive_LMR-REST18 TGTGTGAGGTTTGGTATGTAGT AATAACACCACACATCAACCT 
Constitutive_LMR-REST19 TGAGATAAGGTTAGTATTATGGATAGT ACTAATTTCTTAACTACATCACCAACT 
Constitutive_LMR-REST20 TGTATTTTGGGGATTTTAGGTAGG TCCTCATAACAACCCAAAACT 
Constitutive_LMR-REST21 GGGATGGTGGTTGTTTGTTA ATCTACCCAAACCTCCTCCT 
Constitutive_LMR-REST22 TGGATAGTAGGATTTGGGTTTGT ACAACCTAACAAACATCAATTCCA 
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Constitutive_LMR-REST23 TTGTTTAGGGAGGGGATTGG CCCCAACCCTATAAACAAACA 
Constitutive_LMR-REST24 GATAGTGTGGGGAGTGGATT AACCATACCTCCAAACTTTACA 
Constitutive_LMR-REST25 AGGTTTATGGGTTGGAAGTTT AACACCACAACATCTCAACC 
Constitutive_LMR-REST26 TGTAGTGATTTTAGGATTTTGAGTGT TCAATAAACTCTCCTACAAAATAAACT 
Constitutive_LMR-REST27 TGTGTGAGGTGTAATGTGTG ACTACACAAACAAAACCCAACA 
Constitutive_LMR-REST28 AATGGGAAAGTAAGGTGAAGG TCACTTCAACAAACTTTCCCC 
Constitutive_LMR-REST29 AGGGTAGAATGATTGTTTTAGTGT TCTAAACTCTTAATACCTACCCAAAC 
Constitutive_LMR-REST30 AGGAGTATTTGGTTTGGAGTGA ACTTTCATACACTTCCCACATTT 
Constitutive_LMR-REST31 TTTTAAGGTTGGAAGAGTGAAAGT ACTTCAATCCAACCATCCTCC 
Constitutive_LMR-REST32 GTTGATAGTGGATGTAGTTAAAGGT ACCCAAACAAATAAATCAAACCT 
Constitutive_LMR-REST33 AGATAAATTAGGGAGTGAAGGGA AAAACTCTAACCACCACACCT 
Constitutive_LMR-REST34 TGTTTTATGGAATATTTGGGTTATGT CAACCAACCATCCAACTAACA 
Constitutive_LMR-REST35 GTTTGGTTGGGGTAAAGTTAGT AACCAAAATCATATCACAAATCCA 
Lamda Control1 TGTGTTGGTTGGAAGAGGTT ACTATCACTCTTCTCCTCCTCT 
Lamda Control2 TGTTGTTGGTTGATTTTGATGAG TCCTCTTTCAACTCTACCACA 
Lamda Control3 TTGGATGTATTGGAGAAGTATGAT CCACCATACTAATAATCAAATCTAACA 
T7 Control1 AGTGAGGGTATTGATTTTGAGT ACCTTAAATCTATCACTCAACAAATTC 
T7 Control2 GGGATGGTGAGTTTGTTGAA CCTAATACATCTACAACTACCTCAT 
T7 Control3 TGATTAGTTGAAGGATTGGAAGT TCCCCATCAAACATAAAACCA 
Table 3-6 Bisulfite primer sequences 
 
 
Table 3-7 Probes and primers used for quantitative genotyping (TaqMan).  
Fwd: forward primer, Rev: reverse primer, MGBNFQ=minor-groove binder non-fluorescent 
quencher. All reagents were ordered from Life Technologies. 
  
PCR Fwd Rev probe 5' dye 3' quencher
Dnmt3a GCAGAAGGTACCAGTTTAGAAAGCA TGCCCGCAAGGGACTTTAT AGGAGGGCACCTTAC 6FAM MGBNFQ 
Dnmt3b GCTGTGCAGGCAACATATGG CCTTACGTGACCGAGCTGTCT CAACTAACCGGAGGTTC NED MGBNFQ 
Gapdh GAGCCCCAGGCTATCTCATG GTTCTCCACACCTATGGTGCAA TCTTCAGAGTGGAATACT VIC MGBNFQ 
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3.2.6 Discussion 
Active distal regulatory regions have reduced levels of DNA methylation which critically 
depend on the binding of transcription factors. Recent evidence suggests that 
maintenance and reprogramming of hypomethylated states is achieved through a 
turnover of DNA methylation (see 3.1). However, mechanisms underlying this turnover 
are not well understood. By comparing DNA methylation in embryonic stem cells with 
and without de novo methyltransferases activity we show that the maintenance of 
methylation states at regulatory regions requires de novo methylation. This suggests that 
the observed DNA methylation turnover depends on DNMT3A/B for remethylation and 
thus deletion of de novo methyltransferases can be used for turnover studies. 
Surprisingly, maintenance of methylation states requires de novo methylation also at 
regions which are fully methylated. By profiling DNA methylation at various time points 
following conditional deletion of DNMT3A/B we demonstrate that increased turnover is 
characteristic of low methylated active regulatory regions. Moreover, this accelerated 
turnover at regulatory regions and single cytosines with reduced methylation is 
conserved between biological replicates. Our results provide evidence that DNMT3A/B 
dependent DNA methylation turnover is involved in maintaining a low methylation level at 
active distal regulatory elements.  
Active or passive demethylation? 
The accelerated turnover observed at regulatory regions does not seem to be a random 
event, as it was reproduced across biological replicates at the level of single CpGs 
(Figure 3-5 and 3-6). This observation argues for an active demethylation-remethylation 
process. However, using a replicating cellular system we cannot exclude the involvement 
of a replication-dependent passive demethylation mechanism. The observed 
demethylation is likely to be active if measured turnover rates are higher than those 
inferred from passive demethylation. The following simple calculations are used to 
estimate the mode of demethylation during the observed turnover. 
In case of an exclusively passive demethylation DNA methylation would be diluted at 
each cell cycle by half in the absence of de novo methyltransferases. Assuming one cell 
division in 18 hours - which is rather slow for ES cells (Welham et al, 2011) - a fully 
methylated cytosine would appear almost completely unmethylated after four days 
(Figure 3-8). The inferred turnover coefficient in this case (ß = -0.92) exceeds the highest 
turnover coefficient determined in our time courses (ß = -0.31) by three fold. Thus, the 
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observed turnover is slower than in case of a solely passive demethylation and cannot 
be unambiguously called active. While it is feasible that the turnover does not affect all 
cytosines in a given region simultaneously, it is likely that it involves both active and 
passive demethylation (Hsieh 1999). Turnover studies in postmitotic cells will be required 
to clarify the contribution of active demethylation.  
 
Figure 3-8 Estimation of the turnover coefficient for passive demethylation. 
It was assumed that the ES cells divide once in 18 hours and the starting methylation is 90%. 
Note that the parameter estimated here is the turnover coefficient (not the normalized turnover 
rate). 
DNMT3A/B targeting to sites of increased turnover 
Our data indicate that that the remethylation events contributing to the observed turnover 
depend on DNMT3A/B (see Figure 3-1 and 3-2). Such DNMT3 dependent turnover could 
be mediated by different non-mutually exclusive mechanisms.  
It has been suggested that DNMT3A/B could fill in the gaps left by DNMT1 during 
replication (Chen et al, 2003). One could hypothesize that if the activity of DNMT1 is 
reduced at some regions, this could result in increased dependency of these regions on 
DNMT3A/B for maintaining their methylation. DNMT1 could be prevented from 
maintaining DNA methylation at newly replicated DNA by hydroxymethylation (Inoue and 
Zhang 2011) or TF occupancy (Matsuo et al, 1998). It is thus conceivable that active 
regulatory regions that display both high 5hmC and TF enrichments have lower DNMT1 
activity and are therefore predominantly targeted by DNMT3-dependent turnover.  
Targeting of DNMT3A/B could furthermore depend on the sequence (Luu et al, 2013) or 
simply on the amount of demethylation within a given region. We analyzed two types of 
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inactive fully methylated regions (FMRs) in ES cells - neuronal progenitor specific low 
methylated regions (LMRs) and constitutive FMRs (Figure 3-7). Assuming that only cell 
type specific active regulatory regions are subject to increased turnover, neuronal 
progenitor specific LMRs must have accelerated kinetics in NPs, but not in ES cells. On 
the other hand, if the sequence composition is critical for turnover determination, these 
LMRs must have similarly high turnover rates in any cell type. We could not detect an 
accelerated turnover in progenitor-specific LMRs, when analyzed in ES cells, suggesting 
that DNMT3A/B targeting is not sequence specific. A kinetic analysis in NPs will be 
required for a definite proof of this hypothesis.  
Together, our data clearly demonstrate the dependency of DNA methylation turnover on 
de novo DNA methyltransferases but do not allow drawing conclusions about the actual 
mode of DNMT3A/B targeting. 
Turnover kinetics 
Using an unbiased approach we calculated the turnover rates for cytosines residing 
within different regions. Upon deletion of DNMT3A/B complete demethylation is achieved 
on average after eight days at low methylated regulatory regions and after varying time 
spans at fully methylated non-regulatory sites (see Figure 3-2). While our analysis 
establishes hypomethylated active regulatory regions as sites of enhanced turnover, 
further experiments will be required in order to fully quantify its kinetics. 
It is important to note that the determined turnover rates likely underestimate the speed 
of turnover in ES cells for two reasons. First, bisulfite sequencing does not distinguish 
between methylated and hydroxymethylated cytosines (Huang et al, 2010), so that a 
fraction of “methylated” cytosines could have already undergone a turnover through 
oxidation. In this case we expect the turnover to be even faster at low methylated regions 
as sites of increased hydroxymethylation (see 3.1.2). Further basepair resolution 
analysis of hydroxymethylation will be required to quantify this phenomenon (Booth et al, 
2012; Yu et al, 2012). Second, our conditional deletion approach does not allow for 
analysis of a homogenous population of cells. Throughout the time course, 5-15% of the 
analyzed cells still display activity of DNMT3A/B and could account for the plateau 
observed in Figure 3-2. An experimental system which allows for a complete, 
homogenous and rapid disruption of DNMT3A/B function will be required for a better 
estimation of turnover. Due to rapidly occurring demethylation, this system must enable a 
tight control of DNMT activity. Such experimental approach could utilize a tightly 
regulated Cre-inducible or a protein degradation based system (Feil et al, 1997; Chu et 
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al, 2008). It is furthermore likely that the turnover is slower in postmitotic cells in the 
absence of passive demethylation. 
We note that the turnover kinetics shows some variation among highly methylated 
cytosines with a linear dependency on the methylation level (see Figure 3-6). It is 
possible that cytosines with slightly lower methylation levels (below 80%) are generally 
less accurately maintained by DNMT1 and thus always rely on DNMT3A/B for 
maintenance. This could be affected by the surrounding sequence (Luu et al, 2013) or 
histone modifications. For example, UHRF1 binding to H3K9me3 could reinforce DNA 
methylation maintenance by DNMT1 (Rothbart et al, 2012; Liu et al, 2013). DNMT3A/B 
could furthermore be directed to hypermethylated regions, as both enzymes have been 
shown to tether to methylated nucleosomes in a cancer cell line (Jeong et al, 2009; 
Sharma et al, 2011). It is conceivable that a combination of both mechanisms results in 
increased methylation maintenance of certain regions.  
While the turnover is generally faster at cytosines with low methylation levels, the 
considerable spread in turnover rates present among these CpGs precludes predicting 
the actual turnover kinetics solely from the starting methylation level (Figure 3-5). This 
suggests that additional parameters account for the accelerated turnover. Such 
parameters could include transcription factor binding or nucleosome positioning and are 
discussed in more details below (see paragraph 4).  
  
General Discussion and Conclusions 81 
4 General Discussion and Conclusions 
Active CpG poor regulatory regions display reduced DNA methylation levels which are 
largely dependent on the occupancy by DNA binding factors (Stadler et al, 2011). 
However, the mechanisms underlying the reduction of DNA methylation at these regions 
are poorly understood. During my PhD studies I investigated maintenance and 
reprogramming of DNA methylation at sites of transcription factor binding.  
Genome-wide profiling of the intermediate of active demethylation 5-
hydroxymethylcytosine in stem and neuronal progenitor cells revealed its enrichment at 
active regulatory regions. Together with the observation that CTCF can bind both 
methylated and unmethylated cytosines, our data suggest that reduced methylation can 
be achieved through a transcription factor mediated turnover of DNA methylation. By 
deleting de novo DNA methyltransferases we show that this turnover likely depends on 
DNMT3A/B and predominantly affects active regulatory regions and cytosines with low 
methylation levels.  
Below I will discuss the main findings and elaborate on the implications of these results 
for our understanding of the role of DNA methylation in gene regulation. 
4.1 Transcription factor mediated demethylation 
We used CTCF as example to demonstrate that binding of factors to DNA can mediate 
active turnover of DNA methylation during maintenance and reprogramming of correct 
methylation at distal regulatory regions. Genome-wide mapping of hydroxymethylation 
revealed that its upregulation during cellular differentiation coincides with loss of 
methylation and vice versa. Up to 20% of differentiation-associated changes in 
hydroxymethylation occur at low methylated regions (LMRs), suggesting that this effect 
is characteristic of active regulatory regions. These results are in line with previously 
reported hydroxymethylation dynamics (Serandour et al, 2012; Tan et al, 2013). 
Furthermore, we provide evidence for a direct dependency of 5hmC at a given site on 
the presence of DNA binding factors, as deletion of the TF REST leads to upregulation of 
methylation and decrease of hydroxymethylation at analyzed sites in ES cells. Our data 
mechanistically link transcription factor occupancy to active demethylation. However, 
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since only two factors out of the estimated 1400 in the mammalian genomes were 
studied, it is premature to generalize these findings. 
CTCF can occupy any methylation state in CpG poor sites which are furthermore 
enriched for TET1 and 5hmC. Together with the observed TF binding dependent 
hypomethylated state of these regions, our results are compatible with a scenario where 
TF binding mediates TET-dependent active demethylation. We furthermore show for 
CTCF that its enrichments as determined by ChIP-Seq directly relate to the level of 
demethylation at bound CpGs. The likelihood of being demethylated correlates with the 
frequency of binding for a cytosine within the CTCF binding motif. This relationship could 
be a consequence of accelerated turnover and will be discussed in detail below (4.3). At 
this point it is important to note that the factors CTCF and REST analyzed in this study 
are particular in terms of the length and strength of their binding motifs. In order to 
extend our findings to other factors, a more comprehensive approach will be required. 
Currently, any proposed demethylation mechanism would be speculative and based on 
correlative findings. It seems realistic that such demethylation occurs via TF mediated 
recruitment of TET proteins and subsequent hydroxymethylation (Ding et al, 2012). 
However, since hypomethylation and hydroxymethylation are general characteristics of 
active regulatory regions, this would require physical interactions of many different TFs 
with TET proteins. Alternative scenarios involve TET recruitment by factors frequently 
present at regulatory elements, such as p300 or pioneer transcription factors (Heintzman 
et al, 2009; Serandour et al, 2011). Furthermore, TF binding at regulatory regions could 
cause a change in chromatin conformation which attracts TET proteins (Fu et al, 2008). 
Two explanations for the increased hydroxymethylation at regulatory regions are 
possible. First, hydroxymethylation could solely be an intermediate of active turnover 
(Valinluck and Sowers 2007; Frauer et al, 2011; Kubosaki et al, 2012; Yu et al, 2012; 
Shen et al, 2013; Song et al, 2013). However, it remains to be determined how much 
active turnover contributes to the hypomethylated states at these sites. Second, 
hydroxymethylation might be involved in enhancer function. In this case specific readers 
of 5hmC would be required, as has been suggested for MBD3 and MeCP2 (Yildirim et al, 
2011; Mellen et al, 2012). However, other studies could not detect interaction between 
5hmC and these proteins (Valinluck et al, 2004; Baubec et al, 2013). Furthermore 
counteracting the hypothesis of an autonomous function as a signaling module, 5hmC is 
accumulated in neurons suggesting that it is diluted during replication in dividing cell 
types (Lister et al, 2013). In comparison to 5hmC a larger amount of specific readers has 
been determined for further oxidation products 5fC and 5caC (Spruijt et al, 2013). 
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Indeed, active regulatory regions are enriched for these modifications in the absence of 
TDG (Shen et al, 2013; Song et al, 2013). Again, this argues for a complete processing 
of 5hmC at regulatory sites and thus for active turnover. Based on observations from our 
group and others we favor the hypothesis that 5hmC represents an intermediate in DNA 
methylation turnover at active regulatory regions. 
Together, our findings argue that reduced methylation at regulatory regions is not solely 
a product of passive demethylation. Whether reduced methylation is relevant for the 
activity of regulatory elements remains to be determined. For CTCF it is evident that it 
can bind to methylated CpGs in CpG poor regions (Stadler et al, 2011). It is possible, but 
requires experimental validation, that hypomethylation established by pioneering factors 
is necessary to facilitate access for methylation-sensitive factors (Schubeler 2012).  
4.2 DNMT3-dependent remethylation 
Using embryonic stem cells with deletion of both de novo DNA methyltransferases we 
provide evidence for the presence of a turnover of DNA methylation preferentially at 
active regulatory sites. We show that DNMT3A/B are required for methylation 
maintenance at both hypomethylated regulatory regions and fully methylated regions. 
This finding allowed us to use conditional inactivation of DNMT3A/B to quantify turnover 
kinetics in ES cells. Profiling of DNA methylation throughout a time course upon deletion 
of DNMT3A/B revealed increased demethylation at active regulatory regions. This is 
reproducible between biological replicates at the level of single cytosines, arguing for an 
active targeting. Our results confirm the presence of a DNA methylation turnover 
predominantly at active regulatory regions and furthermore establish its dependency on 
DNMT3A/B. These findings are compatible with the observations made in ES cells 
cultured in 2i medium, in which DNMT3A and DNMT3B are downregulated (Habibi et al, 
2013). 
We show that in the absence of DNMT3A/B methylation is preferentially lost from active 
regulatory regions. In contrast to DNMT1, DNMT3A/B mainly function outside of 
replication (Chen et al, 2003), opening up the possibility that the observed turnover is 
active. However, the kinetics of demethylation is not fast enough to unambiguously 
argue for active turnover (for details see 3.2.6). More conclusive analysis in postmitotic 
cells will be required in order to clarify the contribution of active and passive 
demethylation events in the turnover process. Importantly, it is possible that both modes 
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coexist during demethylation of a given region as has been suggested for EBNA1 
mediated demethylation (Hsieh 1999). 
Increased turnover at regulatory regions is reproducible between biological replicates 
arguing for a regulated targeting of de novo DNA methyltransferases to specific sites. 
How exactly DNMTs are targeted to the sites of turnover and whether this is an active or 
a passive process remains to be determined. A sequence-specific targeting has been 
proposed by several studies (Lin et al, 2002; Handa and Jeltsch 2005). We observed 
that neuronal progenitor specific low methylated regions showing turnover in NPs (see 
3.1) do not represent preferential turnover targets in embryonic stem cells (Figure 3-7). 
Together with the evidence that these sites are enriched for hydroxymethylation in NPs 
(see 3.1), these suggests that the targeting mechanism for DNMT3A/B is not sequence 
dependent. Alternatively, DNMT3A/B might be required to fill in the gaps left out by 
incomplete DNMT1 activity during replication (Chen et al, 2003). In this scenario, 
maintenance methylation would be compromised at sites of increased turnover in a 
process involving for instance TF binding (Matsuo et al, 1998), hydroxymethylation 
(Inoue and Zhang 2011) or both. A third possibility implies replication-independent 
demethylation followed by DNMT3 dependent remethylation. At the moment we cannot 
exclude a function of DNMT1 in turnover. However, this would require preceding strand-
specific demethylation (Song J. et al, 2011; Song et al, 2012). Further analysis in a 
postmitotic system will shed light on the role of DNMT1 in the observed turnover events. 
In conclusion, we confirmed the presence of a DNA methylation turnover in embryonic 
stem cells with a preference for active regulatory regions. This turnover depends at least 
in part on de novo DNA methyltransferases.  
4.3 Transcription factor binding and turnover kinetics 
We established a relationship between transcription factor binding and induction of a 
methylation turnover at regulatory sites. Moreover, by quantifying the kinetics of 
demethylation upon conditional deletion of DNMT3A/B we demonstrate that active 
hypomethylated regions are indeed the preferred turnover targets. While exact numbers 
will have to be corrected upon basepair resolution 5hmC profiling (Yu et al, 2012) and 
turnover analysis in postmitotic cells (see 3.2.6 for details), our quantification allows for a 
comparison between regions.  
General Discussion and Conclusions 85 
We observed differences in turnover kinetics which, only partly, could be attributed to 
differences in methylation levels of individual cytosines (Figures 3-6 and 3-7). These 
differences could result from distinct histone modifications (Rothbart et al, 2012) or 
nucleosome organization (Fu et al, 2008) at turnover sites. Alternatively, but not mutually 
exclusive, the turnover kinetics at a given site changes with differences in the type and 
strength of TF binding at this site. Several scenarios are possible. For instance, 
methylation turnover could correlate with the frequency of transcription factor binding 
(Lickwar et al, 2012). Furthermore, TFs which remain bound to DNA during replication 
(Zaidi et al, 2003; Kadauke et al, 2012; Caravaca et al, 2013) would add a passive 
demethylation component and thus potentially increase the turnover rates at their sites. 
Turnover kinetics of an individual cytosine could also be influenced by its relative position 
to transcription factor sequence motifs. Indeed, in line with a recent study (Jeong et al, 
2014) we observe an accelerated turnover at cytosines located at the borders of 
regulatory regions.  
In summary, turnover kinetics differs between distinct cytosines and regions. Systematic 
analyses of a collection of different transcription factors and / or sequence motifs will be 
required in order to gain conclusive insight into the relationship between occupancy and 
turnover kinetics. 
4.4 Regulatory role of DNA methylation turnover 
Our data argue for a regulated turnover of DNA methylation at transcription factor 
occupied sites. However, whether active turnover or even demethylation has a role in 
enhancer function is not well understood.  
Instructive function of reduced methylation requires methylation-sensitive transcription 
factors. Attempts to categorize transcription factors by their sensitivity to DNA 
methylation have been mostly performed in vitro (Bartke et al, 2010; Hu et al, 2013; 
Iurlaro et al, 2013; Spruijt et al, 2013). Both methylation sensitive and insensitive factors 
have been reported in these studies. Thus, while a subset of TFs can occupy their 
cognate sequences independently of their methylation state, demethylation might be 
necessary for recruitment of other factors. It is possible that a small subset of DNA 
binding factors has a pioneering function in induction of demethylation at a certain locus 
(Zaret and Carroll 2011), thus rendering it accessible for methylation-sensitive factors. 
Repeated remethylation would then preclude promiscuous binding of the latter TFs and 
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thereby reduce transcriptional noise (Chen et al, 2013b). However, in the absence of 
experimental validation this scenario remains speculative. 
High enrichments of TET1 and hydroxymethylation at TF-bound sites suggest a role of 
TET proteins in active demethylation of these regions. We furthermore demonstrate that 
DNMT3A/B are required for maintenance of their methylation states. However, ES cells 
lacking DNMTs (Sakaue et al, 2010) or TET proteins (Dawlaty et al, 2013) largely retain 
their transcriptional signatures, suggesting that turnover is dispensable for the 
maintenance of pluripotent states. Moreover, TET1 and TET2 double knockout mice are 
both viable and fertile (Dawlaty et al, 2013), while gene expression remains stable 
throughout neuronal differentiation of ES cells deficient for DNMT3A/B (data not shown). 
Taken together, data obtained from DNMT and TET knockout animals and cells argue 
against an essential role of DNA methylation turnover in gene regulation.  
4.5 Implications of turnover  
We show that DNA methylation is continuously removed and reestablished at sites of 
transcriptional regulation. This observation contrasts the widely accepted view of high 
heritability of DNA methylation states. At least for CpG poor sites, methylation appears 
largely instable and thus is unlikely to be involved in the propagation of repressive states. 
Furthermore, increased instability of this mark might limit a direct involvement in gene 
regulation at these sites. Importantly, we cannot generalize these findings to other 
genomic regions. Stably silenced genomic regions might utilize additional mechanisms to 
propagate DNA methylation, as has been reported for H3K9me3 (Rothbart et al, 2012; 
Liu et al, 2013).  
In conclusion, we demonstrate the presence of enhanced turnover at transcription factor 
bound distal regulatory regions with reduced methylation. Our studies suggest that 
transcription factor occupancy can trigger demethylation and thus mediate turnover of 
DNA methylation. Mechanistically this turnover appears to be executed by opposed 
activities of TET proteins and de novo DNA methyltransferases in response to 
transcription factor binding. Involvement of the active mode of demethylation during this 
turnover is supported by several lines of evidence. However, whether this is a necessary 
and sufficient mode to create a demethylated region at TF-bound sites requires further 
proof in a postmitotic system.  
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